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E1, an ATP-dependent DNA helicase, is the only enzyme encoded by papillomaviruses (PVs). It is essential
for replication and ampliﬁcation of the viral episome in the nucleus of infected cells. To do so, E1
assembles into a double-hexamer at the viral origin, unwinds DNA at the origin and ahead of the
replication fork and interacts with cellular DNA replication factors. Biochemical and structural studies
have revealed the assembly pathway of E1 at the origin and how the enzyme unwinds DNA using a spiral
escalator mechanism. E1 is tightly regulated in vivo, in particular by post-translational modiﬁcations that
restrict its accumulation in the nucleus. Here we review how different functional domains of E1
orchestrate viral DNA replication, with an emphasis on their interactions with substrate DNA, host DNA
replication factors and modifying enzymes. These studies have made E1 one of the best characterized
helicases and provided unique insights on how PVs usurp different host-cell machineries to replicate and
amplify their genome in a tightly controlled manner.
& 2013 Elsevier Inc. All rights reserved.Introduction
The hexameric DNA helicase E1 is the only enzyme and the
most conserved protein encoded by papillomaviruses (PVs). This
high degree of conservation reﬂects the essential role that E1 plays
during the viral life cycle, namely as the replicative helicase that
orchestrates the faithful copying of the viral episome in the
nucleus of infected keratinocytes. E1 is thought to be required
throughout the viral replicative cycle, ﬁrst to increase the copy
number of the viral episome upon infection of basal keratinocytes,
then to maintain a constant level of episomes in cells that are
displaced upward in the epithelium and begin to differentiate,
and, ﬁnally, to promote ampliﬁcation of the viral genome during
the productive phase of the viral life cycle that takes place in the
uppermost differentiated epithelial layers. Studies in cell culture
have demonstrated that E1 is essential for establishing the viral
genome as a multicopy episome in the nucleus of transfected
keratinocytes,
a process that is believed to mimic, albeit only partially, what
happens to the viral DNA during the early stages of infection.
Cell culture studies have also supported the notion that E1 is
required for the ampliﬁcation of the viral genome that occurs uponll rights reserved.
liniques de Montreal, Labora-
ntreal, QC, Canada H2W 1R7.
J. Archambault).cellular differentiation; some of the evidence coming from the
identiﬁcation of E1 mutant proteins that are speciﬁcally defective
for this process. However, there remains some controversy as to
whether E1 is also needed to maintain the viral episome at a
constant copy number in undifferentiated cells; some studies
suggesting that once the viral genome has been established as a
multicopy episome, its replication and maintenance in proliferat-
ing keratinocytes become E1-independent (Egawa et al., 2012; Kim
and Lambert, 2002).
E1 is a classical initiator protein and, as such, plays several roles
in the initiation and catalysis of viral DNA synthesis. E1 must ﬁrst
recognize a speciﬁc segment of the viral genome known as the
“origin of DNA replication”, or “ori” for short. For most PV types
examined to date, the minimal ori sequence that can support viral
DNA replication in transient assays maps to the 3′ portion of the
viral long control region (LCR), upstream of the early genes, and is
typically comprised of two to three E2-binding sites, a palindromic
E1-binding region and an AT-rich sequence, all of which are
required for optimal ori function (Lee et al., 1997; Lu et al., 1993;
Raj and Stanley, 1995; Russell and Botchan, 1995; Santucci et al.,
1995; Spalholz et al., 1993; Sun et al., 1996; Sverdrup and Khan,
1995; Ustav et al., 1991). As reviewed in detail below, the key step
in the initiation of viral DNA replication at the ori is the assembly
of E1 into its enzymatically active form, a double-hexameric
helicase capable of unwinding the ori and the DNA ahead of the
replication fork, in an ATP-dependent manner. E1 also engages
in multiple interactions with speciﬁc host factors to orchestrate
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replication of the viral genome. The absolute reliance of E1 on host
DNA replication factors for function has contributed to making PV
DNA replication a model system for the study of eukaryotic DNA
synthesis. Furthermore, the central role of E1 in this process and
the availability of crystal structures of the enzyme have made E1
the best-studied member of the superfamily III (SF3) of helicases
(Hickman and Dyda, 2005).
In this article, we will review the structure and function of E1
with an emphasis on the mechanism of DNA unwinding and the
identiﬁcation of functional domains of the protein that mediate
key protein–protein and protein–DNA interactions required for
replication of the PV genome. Like most DNA helicases, E1 is very
stringently regulated, in particular by post-translational modiﬁca-
tions that prevent its over-accumulation in the nucleus. These
regulatory mechanisms and how their failure may contribute to
integration of the viral genome during carcinogenesis will also be
reviewed.Domain structure of E1
The ﬁrst insights into the structure and function of E1 came
from the observation that it shares sequence similarity with the
initiator proteins of other DNA viruses such as the large T antigen
(LT-Ag) of simian virus 40 (SV40) and of other polyomaviruses
(Clertant and Seif, 1984). Four conserved regions, termed A, B, C
and D, were identiﬁed in the C-terminal regions of E1 and LT-Ag
(Fig. 1, lower panel), which suggested that E1 may function as an
ATPase (Clertant and Seif, 1984). Subsequent studies conﬁrmed
that puriﬁed recombinant E1 displays ATPase activity and is in fact
a hexameric DNA helicase with 3′ to 5′ directionality (Fouts et al.,
1999; Hughes and Romanos, 1993; Jenkins et al., 1996; Raj and
Stanley, 1995; Rocque et al., 2000; Santucci et al., 1995; Sedman
and Stenlund, 1998; Seo et al., 1993; Sheikh et al., 2003; White
et al., 2001; Yang et al., 1993). Much of our understanding of the
structure and function of E1 has been gathered from the study of
the prototypical bovine papillomavirus type 1 (BPV1) E1 and, more
recently, of E1s from prevalent anogenital human papillomavirus
types (HPV6, 11, 16, 18, 31 and 33) and the cutaneous virus HPV1.
Thus, one must keep in mind that our understanding of theFig. 1. Domain structure of E1. Diagram of the BPV1 E1 protein highlighting the funct
region is shown in light purple while the domains required for viral DNA-replication in
nuclear localization signal (NLS), DNA binding domain (DBD), minimal oligomerization d
comprise the helicase domain (HD), as indicated. Below the HD are shown the positions
respectively), and arginine-ﬁnger (R). The locations of the four regions (A–D) of homolog
summarizes the main functions of the DBD and HD.structure and function of E1 emanates from E1 proteins from a
very limited set of viruses. Although some of the basic principles
underlying the mechanisms of viral DNA unwinding and replica-
tion have likely been highly-conserved during evolution, the ﬁne
tuning and regulation of E1 activity may have evolved more
rapidly to accommodate differences in the life cycles of different
PV types.
A signiﬁcant issue that has limited the biochemical character-
ization of the E1 helicase to only a few PV types has been the
difﬁculty in expressing and purifying large quantities of the
protein in a recombinant form that can support cell-free DNA
replication. This is in part due to the fact that E1 must assemble
from monomers at the ori in order to be active for DNA replication
but is typically puriﬁed as large pre-formed oligomers when
overexpressed in heterologous systems such as bacteria and insect
cells. A notable exception has been the BPV1 E1 protein which can
be readily puriﬁed from bacteria or insect cells in monomeric form
or as oligomers that are in a monomer–hexamer equilibrium; a
feature that has contributed to making BPV1 E1 the preferred
enzyme for biochemical studies (Bonne-Andrea et al., 1995a; Fouts
et al., 1999; Melendy et al., 1995; Mohr et al., 1990; Müller et al.,
1994; Sedman and Stenlund, 1998). In contrast and as mentioned
above, overexpression of E1 from other PV types often results in
enzyme preparations comprised mostly of oligomers rather than
monomers. For example, HPV11 E1 overproduced in insect cells
using a baculovirus-expression system is puriﬁed mostly as
hexamers that are not easily dissociated into monomers and thus
poorly active in cell-free DNA replication, despite displaying
signiﬁcant levels of ATPase and short-duplex DNA unwinding
activities (Dixon et al., 2000; Rocque et al., 2000; White et al.,
2001). Fortunately, this issue has not been insurmountable and
protocols have been developed to obtain HPV11 E1 from insect
cells in a replication-competent form (Kuo et al., 1994). Mono-
meric and active HPV11 E1 can also be obtained by expression of
the protein in vitro, by coupled transcription and translation in a
rabbit reticulocyte lysate, a facile approach that should be easily
adaptable to the E1 proteins from other PV types (Amin et al.,
2000).
E1 is encoded by the largest and most conserved open-reading
frame (ORF) of the PV genome. The protein ranges in size from 600
to 650 amino acids, depending on the PV type. Overall, the proteinions and amino acid boundaries of its various domains. The N-terminal regulatory
vitro are colored in deep purple. The diagram shows the locations of the bipartite
omain (O), AAA+ ATP-binding domain and C-terminal brace. The latter three regions
of the Walker A (WA), Walker B (WB), β-hairpin (β), sensor 1, 2 and 3 (S1, S2 and S3,
y with the large T antigen of SV40 are also indicated. The bottom part of the ﬁgure
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regulatory region that is essential for optimal replication in vivo
but dispensable in vitro (Amin et al., 2000; Ferran andMcBride, 1998;
Morin et al., 2011; Sun et al., 1998), a central origin-binding domain
(known as the DNA-binding domain, DBD) that recognizes speciﬁc
sites in the ori (Auster and Joshua-Tor, 2004; Chen and Stenlund,
1998; Leng et al., 1997; Saraﬁ and McBride, 1995; Sun et al., 1998;
Thorner et al., 1993; Titolo et al., 2003), and a C-terminal enzymatic
domain sufﬁcient for self-assembly into hexamers that display
ATPase activity and are capable of unwinding short DNA duplexes
(Fig. 1) (Castella et al., 2006b; Enemark and Joshua-Tor, 2006; Titolo
et al., 2000; White et al., 2001). The DBD and C-terminal helicase
domain (HD) are sufﬁcient for ori-dependent DNA replication in vitro
and form the core of the molecular motor that drives viral DNA
replication (Amin et al., 2000).
N-terminal regulatory region
The N-terminal region of E1, comprised of approximately 200
amino acids, is the least conserved segment of the protein. This
region contains a number of short amino acid sequence motifs that
are variably conserved amongst different PVs, including a bi-
partite nuclear localization signal (NLS), a Crm1-dependent
nuclear export signal (NES), a cyclin-binding motif (CBM) that
interacts with cyclin A/E in complex with cyclin-dependent kinase
2 (Cdk2) and phosphorylation sites for Cdk2 and other kinases
(Deng et al., 2004; Fradet-Turcotte et al., 2010a; Leng et al., 1994;
Lentz et al., 1993, 2006; Ma et al., 1999; McShan and Wilson, 1997;
Yu et al., 2007). The less stringent evolutionary conservation of the
E1 N-terminal region likely reﬂects the adaptation of different PVs
for their respective host and the type of epithelium they infect.
For instance, it is easy to imagine that E1 may be regulated slightly
differently in cutaneous versus mucosal tissue. Examples of how
the N-terminal region regulates the nucleo-cytoplasmic shuttling
of E1 slightly differently for different PV types are provided later in
this review article. From a structural biology perspective, little is
known about this N-terminal region, likely because it does not
assume a compact structure as suggested by its accessibility
to proteases. Using NMR, a short 82 amino acid region at the
N-terminus of HPV31 E1 has been found to be unstructured and
may constitute a genuine intrinsically disordered domain (IDD)
(Lehoux et al., 2012). IDDs are common in viral proteins as they
can accommodate interactions with several different protein
partners using a folding-upon-binding mechanism. IDDs tend to
be enriched in charged residues and sites of post-translational
modiﬁcations, such as phosphorylation, as is the case for the E1
N-terminus. The putative IDD of HPV31 E1 contains a binding site
for the cellular protein p80/Uaf1 ((Côté-Martin et al., 2008),
discussed later in this review) followed by a short and conserved
hydrophobic motif, Φ-x-x-Φ-Φ (where Φ are hydrophobic amino
acids) with a propensity to fold as an amphipathic α-helix (Morin
et al., 2011). A triple amino acid substitution in this motif (aa 45–
51, MVDFI changed to AVDAA) was found to reduce transient viral
DNA replication approximately 2-fold, at a step following assembly
of the E1–E2–ori pre-initiation complex, consistent with this
putative amphipathic helix playing a stimulatory, yet unknown
role in viral DNA replication (Morin et al., 2011). Thus, a picture is
emerging where the N-terminal region of E1 may be a privileged
segment of the protein for easily accessible molecular recognition
features (MoRFs) and short linear motifs (SliMs) involved in
regulating E1.
DNA-binding domain (DBD)
The DBD, sometime referred to as the origin-binding domain
(OBD), has been extensively characterized in vitro and was the ﬁrstE1 domain to be crystallized (Auster and Joshua-Tor, 2004;
Enemark et al., 2000, 2002). As its name indicates, the DBD is a
DNA binding domain that recognizes speciﬁc sequences in the ori,
albeit with low afﬁnity. The E1 binding region within the ori was
ﬁrst characterized as an 18-nucleotide AT-rich imperfect palin-
drome (Chen and Stenlund, 2001; Holt et al., 1994; Holt and
Wilson, 1995; Mendoza et al., 1995; Sun et al., 1996; Ustav et al.,
1991; Yang et al., 1991). Further analysis of this region indicated
that it is contains six E1-binding sites (E1BS 1–6) of the consensus
sequence 5′-ATTGTT-3′, although some sites can be degenerate
and of lower afﬁnity (Chen and Stenlund, 2001; Titolo et al., 2003).
Systematic mutagenesis of a single E1BS in vitro revealed that the
E1 DBD binds with higher afﬁnity to sites of the following
consensus sequence: 5′-AT(A/G/T)G(C/T)(C/T)-3′, highlighting the
importance of the A1, T2 and G4 positions for binding (Titolo et al.,
2003). The six E1BS present in the BPV1 origin are shown in
Fig. 5A. Four of those six E1BS correspond to the 18-bp palindrome
mentioned above and are arranged as two pairs of overlapping
inverted repeats (E1BS1 and 3 or E1BS 2 and 4), with both E1BS
within each repeat being separated from each other by three
nucleotides (Chen and Stenlund, 2001; Titolo et al., 2003). As will
be further discussed below, these two pairs of E1BS can each
support dimerization of the E1 DBD. The remaining two sites, E1BS
5 and 6, are also conserved in the ori of several PVs and extend by
3-bp on either side of the palindrome; however, because they are
not paired, they do not support the dimerization of E1 (Fig. 5A)
(Chen and Stenlund, 2001). Rather, E1BS 5 and 6 are thought to
cooperate with the other E1BS to orchestrate the assembly of E1 as
a double-trimer at the ori; a key intermediate complex in the
assembly of a functional double-hexamer (see section on the
initiation of PV DNA replication for more details) (Chen and
Stenlund, 2001; Titolo et al., 2003). Thus, it is believed that the
arrangement of the six E1BS in the ori forms the basis for how six
E1 molecules assemble into a double-trimer at the ori.
The crystal structure of the E1 DBD from BPV1 (residues 159–
303) and, subsequently, that of the HPV18 DBD (210–354) revealed
that this domain adopts a fold similar to that of the SV40 LT-Ag
OBD, despite very limited sequence similarity between both
domains (Auster and Joshua-Tor, 2004; Enemark et al., 2000).
The BPV1 E1 DBD consist of a central ﬁve-stranded anti-parallel
β-sheet ﬂanked by loosely packed α helices on one side (α1, α2, α5
and α6) and more tightly packed helices (α3 and α4) on the other
(Fig. 2A) (Enemark et al., 2000). Previous mutational studies had
demonstrated the importance of several key residues for DNA-
binding (Gonzalez et al., 2000; Thorner et al., 1993), which, when
mapped onto the structure of the DBD, deﬁned two conserved
regions involved in DNA recognition. These two regions are
comprised, respectively, of a loop located between α2 and β1 and
designated as the “DNA-binding loop”, and of helix α4 referred to
as the “DNA-binding helix” (Fig. 2A) (Enemark et al., 2000).
Together, these two regions form a continuous and positively
charged area on the surface of the protein. Subsequent crystal
structures of the DBD bound to DNA indicated that the DNA-
binding loop contacts the ﬁrst three nucleotides of the E1BS (5′-
ATT-3′) while the DNA binding helix interacts with the remaining
three residues of the opposite DNA strand (5′-AAC-3′) (Enemark
et al., 2002). Most of DBD-DNA contacts involved electrostatic
interactions with the phosphate backbone, explaining the relatively
poor speciﬁcity of the DBD for its target site. For the DBD from BPV1,
and likely also for that of HPV11, most of the sequence speciﬁcity
arises from Van derWaal interactions between the DNA-binding loop
and the highly-conserved second thymidine (T2) of the E1BS
(Enemark et al., 2002). This mode of protein–DNA interaction may
not apply to all PV types, however. Indeed, the crystal structure of the
HPV18 E1 DBD suggested that this DBD lacks speciﬁc contacts with
T2, a ﬁnding consistent with the increased afﬁnity of this protein for
Fig. 2. Crystal structure of the E1 DBD. (A) Crystal structure of the BPV1 E1 DBD
highlighting the locations of the DNA-binding loop (pink), DNA binding helix (helix
α4, yellow) and dimerization helix (helix α3, green). (B) Crystal structure of two
BPV1 E1 DBD dimers bound to DNA (PDB accession number 1KSX) (Enemark et al.,
2002). The structure shows the mode of DNA-binding and dimer-formation. It also
shows that the two DBD dimers are bound on separate faces of the double-helix
and do not interact with each other.
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substitutions that impair the DNA-binding activity of the DBD have
been reported (Gonzalez et al., 2000; Thorner et al., 1993; West et al.,
2001; West and Wilson, 2002).
While monomeric in solution, the DBD can dimerize in vitro on
DNA substrates containing two inverted E1BS spaced by 3 base
pairs, as found in the ori (Chen and Stenlund, 2001; Enemark et al.,
2000; Titolo et al., 2003). Dimerization increases the afﬁnity of the
DBD for its target sequence by approximately 10-fold (Titolo et al.,
2003). As most PVs contain two such pairs of inverted E1BS, their
ori could in principle support the assembly of two separate DBD
dimers. Crystal structures of the BPV1 DBD bound to two pairs of
E1BS conﬁrmed this possibility and indicated that the two DBD
dimers assemble on separate faces of the DNA and do not interact
substantially with each other (Fig. 2B) (Enemark et al., 2002). The
DBD dimerization interface is relatively small (500 Å2), hydro-
phobic and involves conserved helix α3 (Fig. 2A) (Enemark et al.,
2000). Mutation of a key residue within α3 of the BPV1 DBD
(A206R) was found to prevent dimerization in vitro and to greatly
reduce the ability of full-length E1 to support transient DNAreplication (Enemark et al., 2000; Schuck and Stenlund, 2005b).
Similar results were obtained for the DBDs of HPV11 and HPV31 E1
(Fradet-Turcotte et al., 2010b; Titolo et al., 2003). The crystal
structure of the HPV18 DBD revealed that it also dimerizes via
its α3 helix, although the latter is shorter than in other DBDs. This
structural difference may contribute to the higher afﬁnity of the
HPV18 DBD for non-speciﬁc DNA, for example if it were to increase
its propensity to dimerize (Auster and Joshua-Tor, 2004; Titolo
et al., 2003). Collectively, these ﬁndings suggest that the DBD
dimerization-interface promotes viral DNA replication by enhan-
cing the afﬁnity and speciﬁcity of E1 towards the ori. As will be
further discussed below, the ability of the DBD to bind DNA as
a dimer is required for the assembly of E1 as a replication-
competent double-hexamer (DH) at the ori.
Surface mutagenesis of the BPV1 E1 DBD was used to identify
other functions of this domain unrelated to DNA-binding (Schuck
and Stenlund, 2006). This approach led to the identiﬁcation of 12
amino acid substitutions that impaired the ability of E1 to support
transient DNA replication while having little to no effect on expres-
sion of the protein in transfected cells. Interestingly, 8 of the 12
substitutions did not affect the ability of E1 to bind the ori in vitro,
suggesting that the function of the DBD in replication is indeed not
limited to DNA-binding. These substitutions could be subdivided into
three classes based on functional assays. One class comprised
substitutions that, despite affecting the activity of E1 in vivo, had
little effect on its activity in vitro in a cell-free DNA replication system
(T188A, N252A, S280A, S281A). Accordingly, these substitutions did
not affect the helicase and unwinding activities of E1 measured in
separate assays. It was hypothesized that these substitutions could
affect the regulation of E1 in vivo, perhaps by phosphorylation as 3 of
the 4 affected residues are potential phospho-acceptor sites. The
second class comprised substitutions that impaired the ability of E1
to support ori-dependent DNA replication in vitro but which had
little effect on its helicase and unwinding activities (V256A, L268A).
These substitutions may affect the ability of E1 to interact with
speciﬁc host DNA replication factors such as replication protein A
(RPA), topoisomerase I (Topo I) and DNA polymerase α-primase (Pol
α-prim). The third class contained amino acid substitutions that also
affected the replication activity of E1 in vitro but in this case by
speciﬁcally inhibiting the ability of E1 to assemble as a double-
hexamer at the ori (R269A, K279A). As will be discussed later in this
review, assembly of the E1 double-hexamer proceeds via a double-
trimer intermediate, whose formation was also impaired by the
R269A, K279A substitutions. Collectively, these studies highlighted
the many different roles that the E1 DBD plays in viral DNA
replication in addition to DNA-binding and dimerization.
Helicase domain (HD)
When produced in recombinant form, the HD of E1 is sufﬁcient
for assembly into hexamers that have short duplex DNA unwind-
ing activity, as shown for the BPV1 and HPV11 enzymes (Castella
et al., 2006b; White et al., 2001). This domain can be subdivided
into three functional regions that cooperate to form an active
enzyme: the minimal oligomerization domain, the AAA+ ATP-
binding module and the C-terminal brace. As Two crystal struc-
tures of the BPV1 E1 HD in its hexameric form have been reported:
one of the hexamer bound to ssDNA and nucleotide cofactors and
the other of the free (i.e. apo) hexamer (Enemark and Joshua-Tor,
2006; Sanders et al., 2007). The different functional regions of the
E1 HD are discussed below in light of these structures.
Oligomerization domain
In vitro, E1 can oligomerize either into a double-hexamer in the
presence of ori DNA and ATP (reviewed in a later section) or into a
Fig. 3. Crystal structure of the E1 helicase domain. Crystal structure of the
hexameric BPV1 E1 HD bound to ADP and single-stranded DNA (PDB accession
number 2GXA) (Enemark and Joshua-Tor, 2006). The six E1 monomers are colored
in blue and green in an alternating fashion. ADP is shown in red. The location of the
DNA is not shown in this ﬁgure for clarity. The ﬁgure shows both cartoon and
surface representations of the HD. The front view depicts how the six monomers
assemble to create a central channel. The side view shows the collar formed by the
six minimal oligomerization domains and the larger subdomain formed by the AAA+
ATP-binding site. The bottom inset highlights the fact that each nucleotide-binding site
is formed at the junction of two E1 monomers.
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Stenlund, 1998; Titolo et al., 2000). E1 self-assembly can also be
detected in the yeast two-hybrid system (Titolo et al., 2000).
Studies both in vitro and in yeast indicated that the HD of E1 is
sufﬁcient for oligomerization (Castella et al., 2006b; Titolo et al.,
2000; White et al., 2001). This domain contains the four highly
conserved regions termed A, B, C and D that share signiﬁcant
similarities with the LT-Ag of SV40 and of other polyomaviruses
(Clertant and Seif, 1984). Three of these conserved regions have
been identiﬁed as important for oligomerization of E1, namely
regions A, B and C, the latter two forming part of the ATPase
catalytic site (Fig. 1) (Titolo et al., 2000). The smallest fragment of
HPV11 E1 that could self-assemble in the yeast two-hybrid system
was comprised of amino acids 353–431 (corresponding to aa
309–386 in BPV1 E1); this region spans conserved region A and
constitutes the minimal oligomerization domain (Fig. 1) (Titolo
et al., 2000). In the crystal structures of the BPV1 E1 hexamer, the
six oligomerization domains form a rigid collar N-terminal to the
ATP-binding sites (Fig. 3). Mutations of highly conserved amino
acids within region A inhibit the ability of E1 to oligomerize
in vitro and to support transient DNA replication in vivo (Titolo
et al., 2000). Likewise, mutations in conserved regions B and C,
which lie outside or the oligomerization domain and form part of
the ATP-binding site, conﬁrmed their importance for E1 oligomer-
ization, consistent with ATP playing a stimulatory role in this
process (Titolo et al., 2000).
AAA+ ATP-binding module
E1 is a member of the SF3 family of helicases, which also
include other helicases encoded by small DNA and RNA viruses
(Gorbalenya et al., 1990; Hickman and Dyda, 2005). This family
is characterized by several highly conserved sequence motifs,
namely the Walker A, Walker B, and C motifs (not to be confused
with conserved regions A-D, Fig. 1) that are characteristic of AAA+
proteins (ATPase associated with various cellular activities)
(Koonin, 1993; Ogura and Wilkinson, 2001). For BPV1 E1, this
AAA+module is located within amino acids 387–579, between the
minimal oligomerization domain and the C-terminal brace (Fig. 1).
The Walker A motif (consensus amongst E1 sequences: G-x4-G-K-
[T/S)], aa 433–440 in BPV1 E1), also known as phosphate-binding
loop or P-loop, and the Walker B motif (consensus Φ-Φ-D-D, aa
476–479) form the core of the catalytic site that binds and
hydrolyzes ATP as a magnesium chelate. The C motif (consensus
Φ-[T/S]-[T/S]-N, aa 520–523), also known as sensor 1, is character-
ized by the presence of an invariant asparagine residue that
contacts the Walker B and the γ-phosphate of ATP. In hexameric
DNA helicases such as E1, each of the six ATPase catalytic sites is
actually formed at the junction of two monomers, which both
contribute amino acids involved in ATP-binding and/or hydrolysis
(Fig. 3). In addition to the Walker A, Walker B and C motif from one
monomer, each ATPase site is comprised of an “arginine ﬁnger”
(R538 in BPV1 E1) and of sensor 2 (K425) and sensor 3 (R493)
motifs provided by the adjacent monomer. By analogy with other
helicases, the arginine ﬁnger likely plays a key role in coupling the
energy of ATP hydrolysis to conformational changes required for
DNA unwinding. Mutagenesis of the Walker A, Walker B, C motif,
“arginine ﬁnger” and sensors 2 and 3 conﬁrmed their importance
for ATP-binding and/or hydrolysis (Abbate et al., 2004; Castella
et al., 2006a; Hughes and Romanos, 1993; Jenkins et al., 1996; Lin
et al., 2002; Liu and Stenlund, 2010; MacPherson et al., 1994;
Mansky et al., 1997; Raj and Stanley, 1995; Rocque et al., 2000;
Titolo et al., 1999; White et al., 2001). In addition to its role in ATP-
binding and hydrolysis, the AAA+ module of E1 also contains
speciﬁc determinants involved in non-speciﬁc binding to single-
and double-stranded DNA, in particular a β-hairpin structure (aa504–508 for BPV1 E1) and a hydrophobic loop (aa 457–467). These
DNA-binding elements are critical for the assembly of E1 at the
origin and for its subsequent DNA unwinding activity, as discussed
in later sections of this review article.
C-terminal brace
The HD contains a short ﬂexible region at its extreme C-terminus
that plays a role in the assembly and stabilization of the E1 hexamer
(Fig. 1) (Whelan et al., 2012). In the crystal structure of the complete
HD of BPV1 E1, the C-terminal 26 amino acids are not resolved
indicating that they are ﬂexible and unstructured, a notion that is
further supported by the sensitivity of these residues to protease
digestion (Sanders et al., 2007). Deletion of this C-terminal extension
was found to impair, albeit not completely, the assembly and stability
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activity of E1 particularly on longer DNA substrates (Whelan et al.,
2012). Analysis of the solution structure of BPV1 E1 hexamers by
Small Angle X-ray Scattering (SAXS) indicated that the negatively
charged C-terminal extension from each monomer contacts a posi-
tively charged cleft on the adjacent subunit and acts as a brace to
stabilize the E1 hexamer (Whelan et al., 2012). It was suggested that
this brace may be important for maintaining the oligomeric state of
E1 during conformational changes induced by ATP-binding and
hydrolysis. As the E1 proteins from all PV types contain a C-
terminal extension similar to that of BPV1 E1, this mechanism of
hexamer stabilization appears to be generally conserved.Fig. 4. Location of the β-hairpins and single-stranded DNA within the E1
helicase central channel. Crystal structure of the hexameric BPV1 E1 HD bound
to ADP and single-stranded DNA (PDB accession number 2GXA) (Enemark and
Joshua-Tor, 2006). The E1 hexamer is colored as in Fig. 3 but with the six DNA-
binding β-hairpins (amino acids 504 to 508) highlighted in different colors. The
single-stranded DNA is omitted to allow for easier visualization of the β-hairpins.Crystal structure of the E1 DNA helicase and the mechanism
of DNA unwinding
Staircase mechanism
The crystal structure of the BPV1 E1 DNA helicase in its hexame-
ric, nucleotide-bound and ssDNA-bound state was a watershed event
in the understanding of how members of this family of AAA+
replicative DNA helicases function (Enemark and Joshua-Tor, 2006).
Until the publication of this structure, there was much confusion
about whether the central pore in these hexameric DNA helicases
encircled ssDNA or dsDNA.With the publication of this structure, and
re-analyses of other AAA+ DNA helicase structures in light of this
new information, the general consensus is that these hexameric
replicative DNA helicases form a donut or torus around a ssDNA
template and operate as motor proteins that travel along one of the
two DNA strands (Enemark and Joshua-Tor, 2006). As such, the
unwinding activity of these helicases is not so much that of “strand-
separating” as it is the resultant displacement of any nucleic acid
annealed to the DNA strand upon which the helicase is translocating.
The structure by Enemark and Joshua-Tor (2006) clearly
demonstrated that the central pore of the hexameric BPV1 E1
helicase contains ssDNA. Within this pore, six sequential sugar-
phosphate residues of the ssDNA backbone get bound by the AAA+
DNA binding β-hairpins of the six E1 monomers comprising the
hexamer (albeit with some interaction of histidine 507 with the
phosphate of the adjacent nucleotide) (Fig. 4). Each of the six DNA-
binding hairpins exists in a slightly different position relative to
the DNA helicase torus, with the E1 monomer in the ATP-bound
conformation having the hairpin positioned most closely to the
face where the 5′ end of the ssDNA extends. The adjacent E1
monomer exists in an ADP-bound state, with the DNA binding
hairpin shifted slightly towards the opposite face of the torus. The
next E1 monomer also exists in an ADP-bound state, but with the
hairpin shifted slightly further away from the 5′ face of the torus.
Subsequent E1 monomers generally also have ADP bound, but in
an increasingly looser conformation, in preparation for ADP
release. Conformational changes in E1 associated with the more
loosely bound nucleotide result in their respective DNA binding
hairpins being shifted further toward the 3′ face of the helicase
torus. (Note that due to space limitations this is a somewhat
abbreviated and simplistic description of the complex subunit
structures described in the original reference, with additional
intermediate structures described for the monomers of the asso-
ciated second hexamer—interested parties are directed to consult
the original reference for more detail (Enemark and Joshua-Tor,
2006)). The authors characterized this right-handed helical struc-
ture of DNA binding hairpins within the central pore as a “spiral
staircase”, and noted that the process of ATP-hydrolysis and the
coincident conformational changes in each E1 monomer would
serve to push each associated sugar-phosphate residue of the
ssDNA template from the 5′ to the 3′ face of the helicase torus,producing the well-established 3′ to 5′ directionality of the E1
helicase. While the “spiral staircase” description is an apt analogy
for the static picture produced by the crystal structure, it does not
reﬂect the dynamic nature of the translocating helicase. A
more apt analogy might be that of a “spiral escalator”, where each
sugar-phosphate residue of the ssDNA template “steps” onto a
DNA binding loop closest to the 5′ face of the torus, and is lifted to
the 3′ face via the conformational changes in that E1 monomer
associated with ATP hydrolysis and release. It should also be noted
that due to the dynamic nature of this model, nucleotides are
constantly loading onto and unloading from the “spiral escalator”;
hence, each helicase hexamer is simultaneously contacting only
four or ﬁve ssDNA nucleotides, even though every nucleotide
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This model of DNA unwinding by E1 implies that the transport
of each and every nucleotide residue through the HD would
require hydrolysis of one ATP (Enemark and Joshua-Tor, 2006).
This energetic cost would be at the upper estimates of what has
been determined for other DNA helicases and may, in reality, be
lower. Indeed, a subsequent structure of the BPV1 E1 helicase
showed that this same “spiral staircase” arrangement can form in
absence of both nucleotide and ssDNA (Sanders et al., 2007). While
Enemark and Joshua-Tor had certainly noted that E1 monomer–
monomer interactions played a role in the slight conformational
changes that create the “spiral staircase” (Enemark and Joshua-Tor,
2006), it was not until the publication of the E1 structure in
absence of substrate that it could be appreciated that E1 mono-
mer–monomer interactions play probably the most vital (and
apparently sufﬁcient) role in creating this spiral arrangement
(Sanders et al., 2007). The implication of this ﬁnding is that one
can now envision that an ATP molecule may not be directly
required for the transport of each ssDNA nucleotide residue up
the “spiral escalator”; conformational shifts caused by ATP-binding
and hydrolysis by only a subset of E1 monomers could be sufﬁcient
to induce the necessary conformational shifts in the other mono-
mers within the hexameric helicase. Indeed, it is possible that as
few as one ATP molecule might be required for the passage of up
to six nucleotide residues through the central pore. This could
account for the varying step-size estimates determined for
E1-related helicases (Singleton et al., 2007).
These results on the E1 helicase are particularly important in
regards to the human replicative helicase complex. The major
motor component of the eukaryotic replicative DNA helicase
complex is a hetero-hexamer composed of the six mini-chro-
mosome maintenance proteins (MCM 2 through 7), which are all
members of the AAA+ DNA helicase superfamily (Bochman and
Schwacha, 2009). While all six MCM proteins are believed to be
essential components of this motor helicase, hetero-hexamers
assembled with an ATPase-dead (Walker motif) version of MCM
2, 3 or 5, or with all three mutant subunits, have been shown to
remain fully functional for ATPase activity; conversely, heterohex-
amers with Walker B mutations in the MCM 4, 6 and 7 subunits
show dramatically decreased ATPase activity (Schwacha and Bell,
2001). As for their effect on the unwinding function of these
mutant complexes, Walker A mutations in MCM 4, 5, 6 or 7 have
been found to ablate DNA helicase activity, while Walker A muta-
tions in MCM 2 or 3 retain moderate to wild-type levels of activity
(Bochman and Schwacha, 2008). While these have been confusing
results for the eukaryotic DNA replication ﬁeld, the ﬁndings on E1
suggesting that only a subset of ATPase sites actually hydrolyzing
ATP may be sufﬁcient for translocation and helicase action, may
explainwhy not all MCM ATPase domains are required for the MCM
complex to be functional.Small-molecule inhibitors of E1 enzymatic activity
The enzymatic activity of E1 has been considered an attractive
target for antiviral drug discovery, speciﬁcally for the treatment of
HPV-associated lesions in which the viral genome is not integrated
but remains episomal, such as in benign anogenital warts caused
by HPV6 and HPV11 infections. However, despite intense high-
throughput screening efforts, only two classes of E1 inhibitors
have been reported. Benzodiazepine-like inhibitors of the ATPase
activity of HPV11 E1 have been claimed in the patent literature (US
patent 6703,387 B2; (Hurst et al., 2004)). Potent biphenylsulfona-
cetic acid inhibitors of the ATPase activity of HPV6 E1 have also
been reported (Faucher et al., 2004), but those were inactiveagainst HPV11 E1 due to the replacement of a single non-
conserved residue within the NTP-binding site of this enzyme
(tyrosine 486 in HPV6 E1 replaced by a cysteine in HPV11 E1)
(Faucher et al., 2004; White et al., 2005). Despite these inhibitors
being active in vitro, they were not effective in cell culture assays,
thus limiting their potential as anti-HPV lead compounds. Why
E1 has remained refractory to pharmacological inhibition is not
completely understood but may be due, at least in part, to the
poorly-discriminating nature of its nucleotide-binding site which,
in the case of HPV11 E1, has been shown to accommodate and
hydrolyze a variety of different NTPs and dNTPs in vitro (Rocque
et al., 2000; Titolo et al., 2000; White et al., 2001).Initiation of papillomavirus DNA replication
Although it is generally accepted that replication of the viral
genome in undifferentiated cells, in transient assays or in vitro
involves a bi-directional replication fork, it has been suggested
that ampliﬁcation of the PV genome during the productive-phase
of the life cycle occurs through a rolling-circle mechanism (Flores
and Lambert, 1997). Because the vast majority of published studies
have investigated how the viral genome is replicated during the
establishment and maintenance stages of the viral life cycle, much
more is known about the bi-directional mode of DNA replication
that is characteristic of these stages. In this section, we will review
how bi-directional replication of the PV genome is initiated by E1
and E2 and the mechanism by which E1 assembles at the ori as a
functional double-hexamer. Most in vitro studies on the assembly
of E1 and E2 at the origin have been performed with the BPV1
proteins and a fragment of the BPV1 origin, designated as the
minimal ori, which contains a single E2-binding site (E2BS), an
E1-binding region and an AT-rich sequence (Fig. 5A). This minimal
ori supports BPV1 DNA replication in transient assays, albeit at
slightly lower levels that the complete ori which contains an
additional E2BS (Fig. 5A) (Ustav et al., 1993). The current model of
initiation of BPV1 DNA replication is schematized in Fig. 5B and
described below together with relevant data obtained with the E1
and E2 proteins of other PV types.Assembly of the E1–E2–ori ternary complex
In vitro, E1 can bind to the ori and drive PV DNA replication
independently of E2 if used at high concentrations and in absence
of non-speciﬁc competitor DNA (Bonne-Andrea et al., 1995a).
In contrast, the modest speciﬁcity of E1 for its target binding sites
prevents it from binding to the ori without the help of E2 when
challenged with large amounts of non-speciﬁc DNA in vitro or in
presence of excess cellular genomic DNA in vivo (Dixon et al.,
2000; Sedman and Stenlund, 1995; Sedman et al., 1997; Titolo
et al., 2003; Yang et al., 1991). The only known exception being the
E1 protein from HPV type 1a, which can support signiﬁcant levels
of viral DNA replication in absence of E2, in transient assays
(Gopalakrishnan and Khan, 1994). For the other PV types, in vivo
recognition of the ori by E1 requires E2, the only other viral
protein needed to initiate DNA replication (Ustav and Stenlund,
1991; Yang et al., 1991). The role of E2 during replication has been
extensively characterized. Its primary role is to act as loading
factor to recruit E1 speciﬁcally at the ori; a task that it accom-
plishes through its ability to bind simultaneously to E1 and to the
E2-binding sites (E2BS) present in the ori (Berg and Stenlund,
1997; Blitz and Laimins, 1991; Frattini and Laimins, 1994; Gillette
et al., 1994; Lusky and Fontane, 1991; Lusky et al., 1993, 1994;
Mohr et al., 1990; Sanders and Stenlund, 1998, 2000, 2001;
Sedman and Stenlund, 1995; Sedman et al., 1997; Seo et al.,
Fig. 5. Model of the assembly of BPV1 E1 at the minimal origin of DNA replication. (A) Diagram of the BPV1 origin (ori) showing the locations of the two E2-binding sites
(designated E2BS11 and E2BS12), of the six E1-binding sites (E1BS) and of the AT-rich region (AT-rich). Also shown is the structure of the minimal ori fragment that lacks
E1BS11 and has been used for most in vitro studies on the assembly of E1 and E2 on DNA. The nucleotide sequence of the six E1BS is indicated underneath the minimal ori.
Two pairs of sites, E1BS 1 and 3 and E1BS 2 and 4, can support the dimerization of E1. E1BS 5 and 6 are not paired and are shown as dashed lines. (B) Schematic
representation of the initiation of BPV1 DNA replication on the minimal BPV1 ori. Replication is initiated by the recruitment of E1 (light purple), by E2 (light blue), to the ori
resulting in the assembly of an E1–E2–ori ternary complex comprised of a dimer of E1 bound to one pair of E1BS (E1BS 1 and 4) and a dimer of E2 bound to E2BS11. This
complex serves as a template for the recruitment of additional E1 molecules and assembly of the E1 double-trimer (DT) intermediate. The E1 DT may not accumulate in vivo
but can be trapped in a stable form in vitro by performing the assembly reaction with a non-hydrolysable nucleotide. Upon ATP-hydrolysis, this E1 DT is rapidly converted
into a double-hexamer in which each of the two hexamers encircles a separate DNA strand. This complex is capable of DNA unwinding and likely serves as a platform for the
recruitment of the cellular DNA replication factors DNA polymerase α primase (Pol α-prim), topoisomerase I (Topo I) and replication protein A (RPA). Further details on the
assembly of E1 at the origin are provided in the text.
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direct E1 to the two pairs of E1BS located in the ori, leading to the
assembly of an E1–E2–ori ternary complex. As will be further
discussed in the next two sections, this E1–E2–ori complex serves
as a template for the assembly of an E1 double-hexamer with
unwinding activity (Sanders and Stenlund, 1998). Two separatedomains of E2 are involved in directing E1 to the origin. One is the
C-terminal dimerization and DNA-binding domain (DBD) that is
sufﬁcient for high-afﬁnity interaction with the E2BS in the ori. The
second is the N-terminal region, better known as the transactiva-
tion domain (TAD) for its role in regulating viral gene transcrip-
tion, which is the domain that directly binds to E1. Interestingly,
Fig. 6. Crystal structure of the E1 ATPase domain in complex with the E2
transactivation domain (TAD). Structure of the complex formed between the E2
transactivation domain (TAD, cyan), and the C-terminal ATPase domain of E1 (light
purple) of HPV18 E1 (PDB accession number 1TUE) (Abbate et al., 2004). The inset
highlights the salt bridge formed between the highly conserved E45 of the TAD
(orange) and R454 of E1 (purple). Also shown is the location of the loop 2 in E1,
which is involved both in E2-interaction and E1 oligomerization, in a mutually
exclusive manner.
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Stenlund, 1997; Bonne-Andréa et al., 1997; Lusky and Fontane,
1991; Masterson et al., 1998; Moscufo et al., 1999; Müller and
Sapp, 1996; Saraﬁ and McBride, 1995; Stenlund, 2003; Sun et al.,
1998; Titolo et al., 1999; Yasugi et al., 1997a), an interaction that
not only helps to recruit E1 to the ori but which also inhibits its
non-speciﬁc binding to DNA (Bonne-Andréa et al., 1997; Stenlund,
2003). Thus, E2 promotes the binding of E1 speciﬁcally at the ori
by two different mechanisms, namely by tethering E1 to the ori
and by preventing its non-speciﬁc interaction with competing
cellular DNA. For BPV1, a second interaction has also been reported
that involves the E1 DBD and E2 DBD (Berg and Stenlund, 1997;
Chen and Stenlund, 1998; Leng et al., 1997; Moscufo et al., 1999;
Woytek et al., 2001). This additional protein–protein interaction
appears to be speciﬁc to BPV1 and reﬂects the peculiar arrange-
ment of E1 and E2 binding sites within the ori of this virus,
speciﬁcally the close juxtaposition of E2BS12 to the E1-binding
region (Fig. 5A) (Berg and Stenlund, 1997). Complex formation
between the DNA-binding domains of both E1 and E2 likely serves
to promote the subsequent interaction of the helicase region with
the TAD (Berg and Stenlund, 1997; Gillitzer et al., 2000), which,
based on functional studies and on its high-degree of conservation
amongst PVs, is thought to be the more “productive” interaction in
the assembly of the E1–E2–ori ternary complex. In vitro, studies
using a BPV1 ori fragment containing a single E2BS indicated that
it can nucleate the assembly of an E1–E2–ori comprised of a single
E2 dimer and two E1 molecules bound at one of the two pairs of
E1BS (E1BS 2 and 4, the highest afﬁnity pair; Fig. 5) (Chen and
Stenlund, 1998).
Because of its central role in the initiation of PV DNA replica-
tion, the E1–E2 interaction has received considerable attention
both from an academic standpoint and as a candidate antiviral
target. A crystal structure of a complex between the E2 TAD (aa
1–215) and E1-HD (aa 428–631) of HPV18 has been reported
(Fig. 6) (Abbate et al., 2004). This structure revealed that both
domains interact in a 1:1 ratio; an observation conﬁrming that the
E1–E2 interaction does not require dimerization of the TAD as
previously suggested by the stoichiometry of the E1–E2–ori
complex (Chen and Stenlund, 1998). The E1–E2 interaction surface
is of medium size (940 Å2) and involves residues located in several
structural elements of both proteins (Abbate et al., 2004). The E2-
binding surface on HPV18 E1 is formed by helices α2 (aa 446–457),
α3 (aa 460–472) α9 (aa 613–624) and an extended loop (loop 2, aa
595–612) preceding α9. Of particular interest is an ionic interac-
tion (salt bridge) between arginine 454 in α2 and a highly
conserved glutamic acid in the E2 TAD (aa 43 in HPV18, Fig. 6)
(Abbate et al., 2004). Previous mutational analyses of E2 from
different PV types had identiﬁed this glutamic acid residue as
important for E1-interaction and viral DNA replication. As antici-
pated, substitution of R454 for alanine abolished the ability of
E1 to interact with E2 in vitro and to support transient DNA
replication in vivo (Abbate et al., 2004). The R454A substitution
did not affect the ATPase activity of E1 demonstrating the selective
role that R454 plays in interaction with E2.
The E1–E2 interaction has also received attention as a candi-
date antiviral target. A series of small molecule inhibitors of this
interaction has been reported that binds to the E2 TAD and
competitively inhibits its binding to the E1 HD (White et al.,
2003). Although these inhibitors bind on the same surface of the
TAD as E1, they make very different contacts with the protein and,
as such, can bind speciﬁcally and with high afﬁnity only to the E2
TADs of the low-risk HPV6 and HPV11 viruses. Like mutations in
E1 and E2 that disrupt their interaction, these compounds inhibit
viral DNA replication in cellular assays. As such, they represent an
interesting starting point for the development of antiviral agents
to treat diseases caused by the low-risk HPV6 and 11 such asbenign genital warts (condylomas) and recurrent respiratory
papillomatosis.
Assembly of the E1 double-hexamer
Although E1 can assemble into hexamers in solution, these
hexamers cannot support ori-dependent DNA replication in vitro.
It is now recognized that bi-directional unwinding and replication
of the viral genome requires the assembly, at the ori, of a double-
hexamer (DH) of E1 in which each of the two hexamers encircles
one of the two DNA strands. For the past decade or so it was
believed that the two hexamers comprising each DH would
remain associated during DNA replication, with the template
DNA being threaded through this dodecameric structure. Only
recently has that paradigm begun to shift back, based on single-
molecule experiments with SV40 large T-antigen indicating that
the two hexamers can separate and track along the opposite
strands during SV40 DNA replication (Yardimci et al., 2012). This
model emphasizes the need for the two hexamers within each DH
to assemble around the two opposite template DNA strands at the
ori. As such, it also provides an explanation for why E1 hexamers
formed in solution cannot support ori-dependent DNA replication,
namely because of their inability to gain access to and encircle one
of the two DNA strands.
Much of our current understanding of the assembly of the E1
DH comes from studies on the BPV1 enzyme by Stenlund and co-
workers. Key to their success was their ability to divide the highly-
cooperative process of DH assembly into discrete steps in vitro, by
trapping different intermediate complexes using mutant or trun-
cated ori substrates, speciﬁc E1 mutant proteins and conditions
permitting ATP-binding versus hydrolysis. The mechanism by
which BPV1 E1 assembles as a DH at the ori in vitro, in absence
of E2 and in a reaction that requires ATP hydrolysis, is reviewed
below.
Assembly of the E1 DH proceeds via the formation of an
intermediate complex comprised of two E1 trimers bound in a
head-to-head conﬁguration, known as the E1 double-trimer (DT)
(Enemark et al., 2000, 2002; Sedman and Stenlund, 1996). Forma-
tion of the E1 DT requires the two pairs of E1BS in the ori that can
promote the dimerization of E1 (E1BS-2 and E1BS 2–4) and likely
also involves the two unpaired sites E1BS 5 and 6; the speciﬁc
arrangements of these six E1BS providing a scaffold for the
assembly of six E1 molecules into a DT (Chen and Stenlund,
2001; Enemark et al., 2000, 2002; Sedman and Stenlund, 1996).
Assembly of the E1 DT also requires sequences on both sides of the
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being contacted by the E1 helicase domain (Enemark et al., 2000,
2002; Sedman and Stenlund, 1996). DT assembly also requires
several functional domains and activities of E1, namely the ability
of the DBD to bind and dimerize on both pairs of E1BS and to also
interact with adjacent E1 molecules, the non-speciﬁc DNA-binding
activity of the HD to contact sequences outside of the E1BS region,
and ATP-binding but not hydrolysis (Chen and Stenlund, 2002;
Enemark et al., 2002; Liu et al., 2007; Schuck and Stenlund, 2005a,
2006). Critical in the assembly of the BPV1 E1 DT are regions of the
HD that mediate non-speciﬁc DNA binding, speciﬁcally the
β-hairpin motif, the hydrophobic loop spanning the invariant
F464 and a charged loop which contain K461 (Liu et al., 2007,
2010). As mentioned previously, amino acid substitutions in the
DBD have also been identiﬁed that speciﬁcally interfere with the
assembly of the E1 DT, without affecting the capacity of the
mutant E1 protein to bind DNA (Schuck and Stenlund, 2006). An
interesting property of the DT complex is that it is sufﬁcient to
melt the ori. Melting is a prerequisite for the transition of the DT
into a replication-competent DH, suggesting that ssDNA is the
substrate on which the DH assembles (Schuck and Stenlund,
2005a, 2007, 2011). Ori melting requires speciﬁc TA base pairs
ﬂanking the E1 BS region and has been proposed to occur as a
result of untwisting of the DNA, caused in part by the movement of
the β-hairpins in response to ATP-binding and hydrolysis (Schuck
and Stenlund, 2005a). Thus, the DNA-binding activities of both the
DBD and HD are required for DT assembly and to melt the ori. It
was suggested that a third DNA-binding activity, associated with
the E1 oligomerization domain and involving conserved K356, also
participates in ori melting (Sanders, 2008), although it has also
been suggested that mutation of this residue impairs the ability of
E1 to oligomerize and interact with E2 (Liu et al., 2007, 2010).
Following its assembly, the E1 DT can be converted into a
replication-competent DH in a process that requires ATP-
hydrolysis. Although the exact mechanistic details by which this
conversion occurs remain to be fully elucidated, it almost certainly
requires, beside ori melting, the assembly of six additional E1
molecules and the rearrangement of the two newly formed head-
to-head hexamers into ring-like structures that each encircle one
of the two DNA strands; these two events being required to
generate a DH complex with non-speciﬁc DNA helicase activity.
Surface mutagenesis of the BPV1 E1 helicase domain has identiﬁed
several amino acid substitutions that speciﬁcally impair the
transition of the E1 DT to E1 DH (I423A, N436A, N444A, S456A
N459A, T490A, N494A, S537A) (Schuck and Stenlund, 2011).
Interestingly, these substitutions all affect residues of the AAA+
module that are located at the interface between monomers in the
BPV1 E1 hexameric structure (Schuck and Stenlund, 2011).
The ﬁndings described above have highlighted the key roles
that the DBD and HD play during the assembly of BPV1 E1 at the
ori. Studies on HPV11 E1 have conﬁrmed the importance of these
two domains in ori-binding but also hinted that the E1 N-terminal
region may be involved. Speciﬁcally, it was found that deletion of
the ﬁrst 71 amino acids of HPV11 E1 increases its binding to the ori
approximately 5-fold in vitro (Titolo et al., 2000). How the N-
terminal region affects the binding and oligomerization of E1 at
the ori remains to be determined.
ATP as an allosteric inhibitor of the E1–E2 interaction
The studies presented above revealed how the E1–E2–ori
ternary complex is assembled at the ori and how E1, in absence
of E2, can assemble into a DH in vitro. EMSA experiments
performed with BPV1 E1 and E2 indicated that these two types
of E1 complexes do not form independently at the ori but, rather,
that assembly of the E1–E2–ori ternary precedes formation of theE1 DH and is in fact a prerequisite for DH assembly (Sanders and
Stenlund, 1998). Furthermore, they revealed that E2 is not an
integral part of the ﬁnal E1 DH complex, suggesting that the
interaction between E1 and E2 is disrupted, and E2 displaced, as
part of the oligomerization process leading to DH formation (Lusky
et al., 1994; Sanders and Stenlund, 1998). The notion that oligo-
merization of E1 is incompatible with E2-binding was further
demonstrated in gel ﬁltration studies indicating that HPV18 E2 can
only bind to monomeric E1 and not to a hexamer (Abbate et al.,
2004). Modeling studies and examination of the E1–E2
and E1 hexamers crystal structures suggest that this speciﬁcity is
dictated in part by the loop 2 region of E1, whose interactions with
the E2 TAD or with another E1 molecule during the oligomeriza-
tion process are mutually exclusive (compare the position of loop
2 in Figs. 3 and 6) (Abbate et al., 2004).
Given that ATP promotes the oligomerization of E1, which in
turn disrupts its interaction with E2, one can think of ATP as an
allosteric inhibitor of the E1–E2 interaction. The converse phe-
nomenon, namely that E2 can act as an inhibitor the ATPase
activity of E1 (which depends on its oligomerizaton), has also been
veriﬁed experimentally. Speciﬁcally, it was observed for HPV11 E1
and E2 that the TAD could increase the Km of E1 for ATP by
approximately 7-fold (White et al., 2001). Thus, ATP and the E2
TAD compete with each other for binding to E1, although they
interact on different surfaces of the helicase domain. These
ﬁndings provide a mechanistic basis to explain how ATP-binding
could favor the transition of the E1–E2–ori ternary complex into
the E1 DT/DH at the ori. This transition is likely further facilitated
by ATP-hydrolysis and the interaction of the E1 HD with DNA, in
particular with the ssDNA that is generated as part of the ori
melting process and upon which a replication-competent DH is
assembled, as discussed above. From a practical standpoint, the
notion that ATP can regulate different steps in the initiation of viral
DNA replication suggests that inhibitors of the ATPase function of
E1 could affect not only the unwinding activity of the enzyme but
also its assembly at the origin.Interaction of E1 with the cellular DNA replication machinery
Small DNA tumor viruses, including PVs, encode only a few
proteins and must therefore rely extensively on their host for the
other functions required to complete their life cycles. Consequently,
most papillomavirus proteins engage in multiple protein interactions
with cellular factors to carry out their activities. E1 is no exception
and has been reported to interact with several members of the
cellular DNA replication machinery (Table 1). These include the DNA
polymerase α-primase (Pol α-prim) complex, replication protein A
(RPA), and topoisomerase I (Topo I). In vitro, papillomavirus DNA
replication also requires replication factor C (RFC), proliferating-cell
nuclear antigen (PCNA) and DNA polymerase δ, even though inter-
action of these factors with E1 has not been reported (Kuo et al.,
1994; Melendy et al., 1995; Müller et al., 1994). The process of viral
DNA synthesis is schematized in Fig. 7 and the various interactions
that E1 makes with key replication factors are reviewed below.
DNA polymerase α-primase complex (Pol α-prim)
Pol α-prim is composed of four subunits of 180 (p180), 70 (p70), 58
(p58), and 48 (p48) kDa, respectively (Wang, 1991). P180 is
the polymerase catalytic subunit, whereas p48 and p58 are the
primase catalytic and auxiliary subunits, respectively. P70 has no
known catalytic function. Pol α-prim is essential for initiation
of DNA synthesis and for the repeated re-initiation events re-
quired for lagging-strand DNA synthesis of the host genome (Wang,
1991). E1 has been shown to interact with Pol α-prim, but when it
Table 1
E1-associated proteins.
E1-
associated
protein
Cellular function of
associated protein
Interaction
region on
associated
protein
Interaction region on E1 Function of interaction References
Pol α-prim DNA replication p70 and/or p180
subunits
Helicase domain interacts
with p70 (aa 353–649 of
HPV11 E1 and aa 397–583
of HPV16 E1)
Replication of viral DNA, direct role
in viral DNA synthesis
Park et al. (1994), Bonne-Andrea et al.
(1995a), Masterson et al. (1998),
Conger et al. (1999),
Amin et al. (2000)
N-terminal fragment of
BPV1 E1 (aa 1–424)
retains binding to p180
RPA Single-stranded DNA-
binding protein
Major ssDNA-
binding domain of
70-kDa subunit
(aa 181–291)
nd Replication of viral DNA, direct role
in DNA synthesis, may help load
RPA onto nascent ssDNA
Han et al. (1999),
Loo and Melendy (2004)
Topo I DNA relaxation nd DBD and helicase domain
of BPV1 E1 independently
bind Topo I
Increases Topo I activity and E1
binding to ori
Clower et al. (2006),
Hu et al. (2006)
p80/Uaf1 WD-repeat protein
associated with
deubiquitinating enzymes
WD-repeats (aa
1–573)
N-terminal region of E1
from anogenital HPV types
(aa 10–40 of HPV11 and
HPV31 E1)
Replication of viral DNA and
episomal maintenance
Côté-Martin et al. (2008),
Lehoux et al. (2012)
Histone H1 Chromatin component nd N-terminal region (aa 1–
185 of HPV11 E1)
E1 can displace histone H1 from
DNA, this may alleviate the
repressive effect of H1 on viral DNA
replication
Swindle and Engler (1998)
Ini1/hSNF5 Subunit of SWI/SNF
chromatin remodeling
complex
nd aa 147–444 of HPV18 E1 Replication of viral DNA, may be
involved in chromatin remodeling
during viral DNA synthesis
Lee et al. (1999)
Hsp40/70 Molecular chaperones J-domain of
Hsp40; nd for
Hsp70
nd Promotes binding of E1 to ori and
assembly into active double
hexamers
Liu et al. (1998), Lin et al., (2002)
E1-BP/
TRIP13
Putative ATPase nd nd Replication of viral DNA,
mechanism unknown
Yasugi et al. (1997b)
p56 Interferon-inducible protein N-terminal region
(aa 29–152)
Helicase domain, aa F399
of HPV18 E1 essential for
interaction
Inhibits helicase activity, interferes
with E1 binding to E2 and to ori,
sequesters E1 in cytoplasm
Terenzi et al. (2008), Saikia et al.
(2010)
Ubc9 SUMO-conjugating enzyme
(E2)
nd DBD and helicase domain
(minimal interaction
region mapped to aa 353–
435 of HPV11 E1)
Replication of viral DNA Rangasamy and Wilson (2000),
Rangasamy et al. (2000), Fradet-
Turcotte et al. (2009), Yasugi et al.
(1997b), Yasugi and Howley (1996)
Caspases-
3/-7
Mediators of apoptosis nd Caspase-cleavage motifs
(D-x-x-D) in N-terminal
region
Viral genome ampliﬁcation in
differentiated cells
Moody et al. (2007)
Cyclin A/E-
Cdk2
Cyclin-dependent kinases
that regulate Caspase-
cleavage motifs (D-x-x-D) in
N-terminal region
Cyclin A and
cyclin E
Caspase-cleavage motifs
(D-x-x-D) in N-terminal
region
Phosphorylation of HPV11 and
HPV31 E1 inhibits their nuclear
export, phosphorylation of BPV1 E1
promotes its shuttling
Cueille et al. (1998), Ma et al. (1999),
Deng et al. (2004), Hsu et al. (2007),
Fradet-Turcotte et al. (2010a)
ERK1 and
JNK2
MAP kinases (MAPK) nd MAPK docking motifs in
helicase domain (aa 505–
520 and 541–545 of HPV11
E1)
Promotes nuclear import of E1 Yu et al. (2007)
Importins
α3/α4/α5
Nuclear import of proteins nd NLS Mediates nuclear import of E1 Bian et al. (2007)
Crm-1
exportin
Nuclear import of proteins nd NES Mediates nuclear export of E1 Deng et al. (2004), Fradet-Turcotte
et al. (2010a), Hsu et al. (2007).
nd, Not determined.
M. Bergvall et al. / Virology 445 (2013) 35–56 45
Fig. 7. Proposed model for the papillomavirus DNA replication fork. The E1 protein (in purple) is shown oriented with its N-terminal DNA-binding domain (DBD)
facing towards the unwound dsDNA. For simplicity, only one of the two hexamers is shown. The E1 helicase encircles the ssDNA template for leading strand DNA
synthesis, pumping the ssDNA template through the E1 complex from the E1-DBD side towards the E1 HD side. Interaction of topoisomerase I (Topo I) (in pink) with
the DBD assists both in E1 origin binding/speciﬁcity and targets Topo I to the incoming dsDNA, where its action is necessary for progression of the replication fork.
Interaction of replication protein A (RPA) (in blue) with the DBD is involved in loading RPA onto the lagging strand ssDNA template newly unwounded by the E1
helicase action. The interaction of the HD with polymerase α-primase (Pol α-prim) (in yellow) may stimulate primer synthesis. As each short RNA-DNA primer is
synthesized by Pol α-prim, replication factor C (RFC) (in orange), in coordination with RPA, prevents Pol α-prim re-association and loads PCNA (in green) and DNA
polymerase δ (in green) onto the recessed 3′ DNA end, assembling a processive DNA polymerase complex. The various interactions of E1 with Topo I, RPA and Pol α-
prim, as well as the interactions between the cellular factors themselves, are coordinated physically and temporally in a highly-organized sequential manner necessary
for replication fork assembly and function.
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differing results (Amin et al., 2000; Bonne-Andrea et al., 1995b;
Conger et al., 1999; Masterson et al., 1998; Park et al., 1994). One
group reported that BPV1 E1 binds p180 in vitro and that the C-
terminal 182 residues of E1 are not required for this interaction (Park
et al., 1994). Two other groups showed that HPV11 and HPV16 E1 do
not interact with p180 in vitro but, rather, bind to p70 through their C-
terminal HDs (Amin et al., 2000; Masterson et al., 1998). For HPV11,
interaction between the E1 HD and p70 was also conﬁrmed in the
yeast two-hybrid system (Amin et al., 2000). Finally, a fourth group
suggested that HPV11 E1 binds to both p70 and p180 in vitro (Conger
et al., 1999). The latter study also revealed that E1-dependent DNA
replication in a cell-free extract could be inhibited by the addition of
free p180 but not of free p70. This is in contrast to Amin et al. who
demonstrated that free p70 could competitively prevent the interac-
tion of HPV11 E1 with Pol α-prim and inhibit E1-dependent DNA
replication in vitro (Amin et al., 2000). Thus, it remains possible that
E1 interacts with both p70 and p180 through different domains and
for slightly different purposes during viral DNA replication. These
somewhat conﬂicting results are reminiscent of ﬁndings with SV40 LT-
Ag, which has also been shown to interact with p70 and/or p180. For
SV40 LT-Ag, however, it has been shown recently that the interaction
with p70 appears to be more critical for SV40 DNA replication (Zhou
et al., 2012). Interestingly, it was found that Pol α-prim and free p70
competes with E2 for binding to E1, suggesting that Pol α-prim
interacts with E1 only following the removal of E2 from the pre-
initiation complex and the subsequent assembly of E1 into an active
DH (Amin et al., 2000; Conger et al., 1999; Masterson et al., 1998).Replication protein A (RPA)
Human RPA is a single-stranded DNA-binding protein
involved in many aspects of DNA metabolism, including DNA
replication, repair, and recombination (Wold, 1997). It is a highly
structured, heterotrimeric complex consisting of three subunits:
a 70-kDa subunit (RPA70), a 32-kDa subunit (RPA32), and a 14-
kDa subunit (RPA14), containing multiple ssDNA binding motifs.
E1 has been shown to interact with the 70-kDa subunit of RPA,
and speciﬁcally within the major ssDNA-binding domain of this
subunit (Han et al., 1999; Loo and Melendy, 2004). Mechanistic
studies performed in vitro suggested how E1 may facilitate the
loading of RPA onto ssDNA at the replication fork. The binding of
RPA to ssDNA and E1 appear to be mutually exclusive; when RPA
is bound to ssDNA it can no longer bind to E1. Also RPA
preferentially binds to ssDNA molecules that have been pre-
bound to E1; when RPA is introduced to ssDNA molecules where
some of them are bound to E1 and some of them are free, the
creation of the RPA-ssDNA complex occurs at the expense of the
E1-ssDNA population, not at the expense of the free ssDNA
population. Interestingly, no ternary E1-RPA-ssDNA complex
has been detected. Together these ﬁndings led to the ﬁrst
described model for active “loading” of RPA onto ssDNA being
expelled from a DNA helicase, and may describe a general
process for DNA helicases and their cognate ssDNA binding
proteins (Loo and Melendy, 2004). Indeed, very similar ﬁndings
and a nearly identical model were subsequently proposed for
the SV40 LT-Ag helicase (Jiang et al., 2006).
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Topo I is an ATP-independent protein that modiﬁes the
topology of supercoiled DNA, acting as a swivel to decrease
torsional stress on DNA. Topo I has been shown to interact with
both the DBD and the C-terminal domain of BPV1 E1 in vitro
(Clower et al., 2006). These interactions increase the activity of
Topo I (Clower et al., 2006; Hu et al., 2006). Once again
similarities are seen between E1 and SV40 LT-Ag. LT-Ag also
interacts with Topo I (Simmons et al., 1996) and this interaction
has been shown to play several roles in SV40 DNA replication,
including stimulating the binding of LT-Ag to the origin (Gai et al.,
2000; Simmons et al., 2004; Simmons et al., 1998; Trowbridge et al.,
1999). Similarly, Topo I has been shown to increase the binding of
BPV1 E1 to the ori and its assembly into the oligomeric helicase
in vitro (Clower et al., 2006). The interaction between Topo I and LT-
Ag has been shown to be important for SV40 as LT-Ag mutants
compromised speciﬁcally in binding Topo I are defective for SV40
DNA replication both in vitro and during virus infection (Khopde
et al., 2008; Khopde and Simmons, 2008). It is currently unknown
whether the E1-Topo I interaction will play as important a role for
DNA replication.Interaction of E1 with other cellular proteins
In addition to the known DNA replication factors mentioned
above, E1 has also been reported to associate with other cellular
proteins to assist and/or regulate viral DNA replication (Table 1).
Among these are p80, hSNF5, histone H1, E1BP and p56, described
below.
p80/Uaf1
Tandem afﬁnity puriﬁcation of HPV11 E1 revealed that it
interacts with the cellular WD-repeat-containing protein p80 (also
known as WDR48 or USP1-associated factor 1 (UAF1)) (Côté-
Martin et al., 2008). The p80-interaction domain on E1 was
mapped to amino acids 10–40 of the N-terminal regulatory region.
The E1-p80 interaction was found to be conserved for HPV6, 11, 16,
18 and 31 but not for HPV1, BPV1 or CRPV, suggesting that it is
speciﬁc to anogenital types (Côté-Martin et al., 2008). Microscopy
studies revealed that p80 is re-localized from the cytoplasm to
discrete nuclear foci induced by E1 and E2 (Côté-Martin et al.,
2008; Lehoux et al., 2012). Chromatin immunoprecipitation assays
further revealed that p80 is recruited to the viral origin (Lehoux
et al., 2012). Double amino acid substitutions in HPV31 E1 that
abrogate p80-binding (W17A/F18A, V20A/E21A, and V23A/I24A)
were found to reduce transient viral DNA replication by 70%,
without affecting the interaction of E1 with E2 or its assembly at
the origin in vivo (Lehoux et al., 2012). In the context of the
complete viral genome, these same substitutions were found
to inhibit the maintenance of the viral episome in immortalized
keratinocytes, suggesting a key role for the E1-p80 interaction in
this process (Côté-Martin et al., 2008). Interestingly, overexpres-
sion in trans of a 40 amino acid long p80-binding peptide, derived
from HPV31 E1, was found to inhibit transient viral DNA replica-
tion by preventing the recruitment of endogenous p80 to the
origin (Lehoux et al., 2012). Characterization of this peptide by
NMR showed that the p80-binding domain of E1 is intrinsically
disordered in solution (Lehoux et al., 2012). Collectively, these
studies highlighted the importance of the E1-p80 interaction for
the replication and maintenance of the viral episome. While the
cellular function of p80 remains to be clearly established, recent
studies have shown that it can associate with de-ubiquitinating
enzymes (Cohn et al., 2009; Cohn et al., 2007; Kee et al., 2010).Whether these enzymes play a role in viral genome replication
and maintenance remains to be determined.Histone H1 and Ini1/hSNF5
The PV genome is associated with nucleosomes in both infected
cells and in virions. Given that viral DNA replication takes place in
the context of chromatin, it is not surprising that E1 was found to
interact with proteins that can modify chromatin structure. In one
study, the N-terminal 185 amino acids of HPV11 E1 were found
to interact with histone H1, whose primary function is to bind
nucleosome-organized chromatin to create an ordered, more
compact DNA structure (Swindle and Engler, 1998). Interestingly,
E1 could displace H1 bound to DNA in vitro. This result led the
authors to hypothesize that E1 may interact with histone H1 as a
means to relieve the repressive effect that chromatin exerts on
viral DNA replication in vivo.
In another study, HPV18 E1 was found by yeast two-hybrid
screening to interact with Ini1/hSNF5, a subunit of the SWI/SNF
chromatin remodeling complex (Lee et al., 1999). The interaction
was also observed with HPV11 E1 and, to a lesser extent, with
BPV1 E1. The minimal fragment of HPV18 E1 that could interact
with Ini1/hSNF5 was comprised of amino acids 147–444, which
spans the DBD and minimal oligomerization domain. HPV18 DNA
replication was found to be stimulated by overexpression of Ini1/
hSNF5, and, conversely, to be inhibited by an Ini1/hSNF5 antisense
RNA. Furthermore, amino acid substitutions in E1 (S225P/F226S
and L305K in the DBD, N395H/A396E and H418E/Y419H in and
near conserved region A, respectively) were identiﬁed that
reduced binding to Ini1/hSNF5 and abrogated transient HPV18
DNA replication. These functional results led the authors to
conclude that the E1-Ini1/hSNF5 interaction is required for HPV
DNA replication (Lee et al., 1999). As a cautionary note, it needs to
be pointed out that most of the amino acid substitutions described
in this study affect highly conserved residues of E1 and, hence, are
likely to also impair other activities of the protein, such as ori-
binding, oligomerization and ATP-hydrolysis, required for viral
DNA replication.Hsp40 and Hsp70
The two molecular chaperones, Hsp40 and Hsp70, have
been found to promote the binding of HPV11 E1 to the ori
in vitro (Liu et al., 1998). These chaperones enhance the
binding of E1 to DNA, independently and by different mechan-
isms, such that their effects are additive. In a process requiring
ATP-hydrolysis, Hsp70 was found to interact transiently with
E1 and enhance its binding to DNA as a hexamer. On the other
hand, Hsp40 promoted the binding of E1 to the ori as a double-
hexamer (Liu et al., 1998). In a cell-free DNA replication assay
based on recombinant HPV11 E1 and E2, Hsp40 and Hsp70
stimulated DNA synthesis by approximately 2-fold (Liu et al., 1998).
A subsequent study revealed that these chaperones are also able to
dissociate E2 from E1-ori complexes and to reverse the inhibitory
effect that E2 imparts on the helicase activity of E1 (Lin et al., 2002).
Thus, Hsp40 and Hsp70 stimulate viral DNA replication by at least two
mechanisms, ﬁrst by helping to dissociate E1 from E2 at the ori and,
second, by facilitating the assembly of a replication-competent double-
hexamer (Lin et al., 2002). It was also suggested that chaperone
proteins may act to recycle E1 double-hexamers, by dissociating them
into monomers capable of re-initiating DNA replication (Liu et al.,
1998). Because these studies were all performed in vitro, it remains to
be determined if the proposed mechanisms of action of Hsp40 and
Hsp70 also apply in vivo.
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The putative ATPase E1-BP (also known as thyroid hormone
receptor interactor 13, TRIP13) was identiﬁed as an HPV16 E1-
interacting protein from a yeast two-hybrid screen (Yasugi et al.,
1997b). Amino acid substitutions in HPV16 E1 that prevent its
association with E1-BP were identiﬁed (Y412F, W439R, W439L,
G482D, G496R) and found to impair viral DNA replication, con-
sistent with a role for E1-BP in this process (Yasugi et al., 1997b).
Unfortunately, and as discovered by the authors, the interpretation
of these ﬁndings was complicated by the fact that many of these
amino acid substitutions also impaired other activities of E1, such
as its ATPase activity, oligomerization, and interaction with E2
and/or Ubc9. Thus, further experiments will be required to
determine the exact role of E1-BP in viral DNA replication. This
study was amongst the ﬁrst to highlight the extreme sensitivity of
the E1 HD to structural perturbations, and specﬁcally, that most
amino acid substitutions in this domain are pleiotropic resulting in
inhibition of E1 oligomerization, ATPase activity and interaction
with E2 or with cellular proteins such as Ubc9 and Ini1/hSNF5.
From a structural point of view, these pleiotropic effects can be
explained by the interdependence of the minimal oligomerization
domain, ATP-binding site and C-terminal brace for proper assem-
bly and functioning of the HD.p56
Another yeast two-hybrid screen, this time using HPV18 E1 as the
bait, identiﬁed p56, a cellular protein induced by interferon (IFN), as
an E1-interacting protein. Interaction with p56 was also detected for
HPV11 and HPV31 E1. Interestingly, p56 was found to inhibit HPV
DNA replication by interacting directly with E1 and sequestering it in
the cytoplasm (Terenzi et al., 2008). In addition, p56 was found to
inhibit the helicase activity of E1 and to also interfere with its binding
to E2 and to the viral origin in vitro (Saikia et al., 2010; Terenzi et al.,Fig. 8. Nucleo-cytoplasmic shuttling motifs in the N-terminal regulatory region o
indicated. The position of the ﬁrst amino acid in each sequence is indicated (number
indicated by a double-arrow and highlighted in yellow. The nuclear export signal (NES)
Putative and known Cdk-phosphorylation sites, [S/T]-P, are colored in pink. Note the ab
from high-risk HPV types and from BPV1.2008). The amino acid phenylalanine 399 (F399) in HPV18 E1 was
identiﬁed as critical for p56 interaction. Deletion of F399 did not
impair viral DNA replication but rendered the process insensitive to
inhibition by IFN (Saikia et al., 2010). In contrast, other studies
showed that alanine substitution of the analogous residue in
HPV11 E1 (F393) and HPV31 E1 (F372) completely abrogated
transient DNA replication even in absence of IFN treatment (Fradet-
Turcotte et al., 2010b; Titolo et al., 2000). The reason for this
discrepancy is unknown. F399 is highly conserved among E1 proteins
of different PV types, with either F, W, and rarely Y being found at
this position. In the BPV1 E1 structure, this hydrophobic residue is
buried and forms part of the enzyme minimal oligomerization
domain. Whether p56 exerts its antagonistic effect by preventing
the oligomerization of E1 has not been determined. The interaction
of p56 with E1 may represent a new type of antiviral mechanism
against PVs, mediated by IFN.E1 intracellular localization
E1 accumulates primarily in the nucleus when expressed in
transfected cells, in agreement with PV DNA replication taking
place in this cellular compartment. Although E1 is located primar-
ily in the nucleus at the steady-state, studies on HPV11, HPV31 and
BPV1 E1 have shown that these proteins actually shuttle between the
nucleus and cytoplasm, using a combination of nuclear localization
and export signals. Importantly, this shuttling process appears to be
highly regulated by phosphorylation, likely as a means to control the
overall levels of viral DNA replication and ensure its appropriate
timing during S-phase.
E1 nuclear import
Studies aimed at identifying the localization signal (NLS) of BPV1
E1 revealed that it lies in the N-terminal regulatory region of thef E1. Sequence alignment of the E1 shuttling module from different PV types, as
in parentheses). The location of the bipartite nuclear localization signal (NLS) is
and cyclin-binding motif (CBM) are shaded in light blue and purple, respectively.
sence of some of these nucleo-cytoplasmic shuttling motifs in several E1 proteins
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negatively charged amino acids separated by approximately
30 residues (Leng et al., 1994; Lentz et al., 1993; Yu et al., 2007). Later
studies on HPV11 and HPV31 E1 conﬁrmed these ﬁndings (Deng et al.,
2004; Fradet-Turcotte et al., 2010a; Lentz et al., 1993; Yu et al., 2007).
The N-terminal basic region of the NLS is the most highly conserved,
with the sequence KRK being present in 495% of E1 types (Fig. 8).
Substitution of the ﬁrst two amino acids of this sequence by glycine, or
of all three residues by alanine, was found to abrogate the nuclear
accumulation of E1 from BPV1, HPV11 and HPV31 (Fradet-Turcotte
et al., 2010a; Lentz et al., 1993; Yu et al., 2007).
Studies on BPV1 E1 revealed that the protein can bind to
importins α3, α4 or α5 in vitro and that these importins can
mediate nuclear import of E1 in digitonin-permeabilized cells
(Bian et al., 2007; Castella et al., 2006b). Interestingly, the BPV1
E1 NLS is surrounded by several putative phosphorylation sites
including T102 and S109 which ﬂank the C-terminal basic region
of the NLS (TPVKRRKS, aa 102–109). T102 can be phosphory-
lated by Cdk1 in vitro (Lentz et al., 1993). S109 can be phos-
phorylated by PKA and PKC in vitro (Zanardi et al., 1997) and is
also one of several sites that are phosphorylated in recombinant
BPV1 E1 puriﬁed from insect cells (Lentz et al., 2006). Results
using mutant E1 proteins in which T102 and S109 were changed
to either alanine to prevent phosphorylation or to aspartate as
phosphomimetics, suggested that these residues are not
required for E1 nuclear import but, rather, that phosphorylation
of S109 may negatively regulate this process by disrupting the
interaction of the NLS with its cognate importins (Bian et al.,
2007; Castella et al., 2006b). Interestingly, a previous study had
demonstrated that substitution of S109 by alanine (S109A)
results in a mutant BPV1 genome with increased replication
capacity, while substitution for glutamic acid decreases replica-
tion (Zanardi et al., 1997). This same study also demonstrated
that the S109A E1, puriﬁed from insect cells, has a higher afﬁnity
for the ori in vitro than the wild type protein. Together, these
ﬁndings suggest that phosphorylation of S109, presumably by
either PKA or PKC, negatively regulates the import of E1 into the
nucleus and its afﬁnity for the viral origin, resulting in lower
replication of the viral genome.
For HPV11 E1, nuclear import of the protein was found to be
stimulated by phosphorylation. Indeed, HPV11 E1 was shown to
interact with and to be phosphorylated by extracellular signal-
regulated kinase 1 (ERK1) and c-Jun N-terminal protein kinase
(JNK2), two mitogen-activated protein kinase (MAPK) family mem-
bers (Yu et al., 2007). Two functional MAPK docking motifs were
identiﬁed in the HD of HPV11 E1 (between aa 505–520 and aa 541–
545, respectively), which are both conserved among many HPV E1
proteins and the BPV1 enzyme. Amino acid substitutions in either or
both of these motifs were found to severely compromise the nuclear
import of HPV11 E1 (Yu et al., 2007). ERK1 and JNK2 are proline-
directed kinases and, as such, can phosphorylate substrates at similar
sites as Cdk1 and Cdk2 (consensus sequence [S/T]-P). A double amino
acid substitution of S89 and S93 by alanine was found to reduce
nuclear accumulation of HPV11 E1 to the same extent as mutational
inactivation of the MAPK docking motifs (Yu et al., 2007). In contrast,
phosphomimetic substitutions had less of a deleterious effect. These
results led to the suggestion that phosphorylation of S89 and S93 by
MAPK is the key event that stimulates the nuclear import of HPV11 E1
(Yu et al., 2007). As will be discussed below, S89 and S93 can also be
phosphorylated by Cdk2 to prevent the nuclear export of E1. Thus,
both MAPK and Cdk2 act on S89 and S93 to promote the nuclear
accumulation of E1, but by opposite mechanisms.
Finally, it is worth keeping in mind that some E1 proteins
may be differentially affected by MAPK phosphorylation. For
example, it was found that a mutant BPV1 E1 in which all three
[S/T]-P sites were changed to alanine could still accumulate inthe nucleus of transfected cells to the same extent as its wild
type counterpart (Hsu et al., 2007), a result indicating that
phosphorylation of the protein neither is required nor stimu-
lates its nuclear import. It would be of interest to determine if a
similar result would be obtained by mutation of the MAPK
docking motifs in BPV1 E1 and, more generally, if BPV1 is a
substrate of MAPK. Furthermore, as the nucleo-cytoplasmic
shuttling of BPV1 E1 is promoted by Cdk2-phosphorylation of
the protein (discussed below), it would be important to deter-
mine if this process is also regulated by MAPK.
Regulation of E1 nucleo-cytoplasmic shuttling
by Cdk2-phosphorylation
The HPV11 and HPV31 E1 proteins were found to contain a
leucine-rich nuclear export signal (NES) located within their N-
terminal region (Deng et al., 2004; Fradet-Turcotte et al., 2010a).
This NES is conserved in most, but not all, E1 proteins (Fig. 8). It
is typically located between the two basic regions of the NLS
and of the consensus sequence L-x(2–3)-L-x2-(L, I, V)-x-(L, I).
Leucine-rich NESs are recognized by the Crm1 exportin. Accord-
ingly, substitutions of conserved hydrophobic residues in the
NES of HPV11 and HPV31 E1 (L110A/I113A in HPV11 E1 and the
analogous double substitution in HPV31 E1), or treatment of the
cells with the Crm1 inhibitor leptomycin B (LMB), were shown
to inhibit nuclear export of these proteins (Deng et al., 2004;
Fradet-Turcotte et al., 2010a).
Interestingly, the Crm1-dependant nuclear export of HPV11 and
HPV31 E1 was found to be inhibited by Cdk2 phosphorylation.
Indeed, in addition to the NLS and NES, the N-terminal regulatory
region of many HPV E1 proteins also contains a cyclin-binding motif
(CBM) located next to the NLS/NES region as well as several putative
Cdk2 phosphorylation sites (consensus [S/T]-P) (Fig. 8). For HPV11
and HPV31 E1, it has been demonstrated that the CBM (consensus
R-x-L, aa 124–126 in HPV11 E1) can bind to cyclin A/E-Cdk2 and
that a double alanine substitution within this interaction motif (RRL
to ARA) results in a mutant E1 that is no longer phosphorylated and
thus constitutively exported to the cytoplasm (Deng et al., 2004;
Fradet-Turcotte et al., 2010a). Furthermore, HPV11 and HPV31 E1
have been found to be substrates of Cdk2 in vitro and in vivo,
respectively (Deng et al., 2004; Fradet-Turcotte et al., 2010a; Ma
et al., 1999). Mutational analysis coupled to functional studies
indicated that Cdk2-phosphorylation of three serine residues
located near (S89 and S93) and within the NES (S107) of HPV11
E1 inhibits its nuclear export (Deng et al., 2004; Fradet-Turcotte
et al., 2010a). Similarly, it was found that nuclear export of HPV31
E1 is inhibited by Cdk2-phosphorylation of S92 and S106 (Deng
et al., 2004; Fradet-Turcotte et al., 2010a; Yu et al., 2007). Surpris-
ingly, while the S107A substitution in HPV11 E1 almost completely
inhibited the ability of the protein to support transient DNA
replication, the analogous substitution S106A in HPV31 E1 had no
such effect (Deng et al., 2004; Fradet-Turcotte et al., 2010a),
suggesting that this serine residue may have additional functions
in the E1 protein of low-risk HPV types, besides regulating its
nuclear export. Thus, phosphorylation of HPV E1 by cyclin A/E-Cdk2
ensures that E1 is retained in the nucleus at the onset and during
S-phase, and may serve as a mechanism to synchronize viral DNA
replication with host DNA synthesis.
The ﬁndings summarized above are likely to apply to the
E1 proteins of many PV types but perhaps not to all of them given
that some lack an easily recognizable NES or CBM sequence. For
example, the E1 protein of high-risk HPV33 lacks both the NES and
CBM (Fig. 8). Other E1 proteins, like that of BPV1 E1, contain only a
CBM but no obvious NES (Fig. 8). Despite lacking a NES in its
N-terminal region, BPV1 E1 was shown to shuttle between the
nucleus and cytoplasm in a Crm1-dependent fashion (Hsu et al.,
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for a NES in other regions of the protein. A Crm1-dependent NES
was identiﬁed in the HD of BPV1 E1, between aa 408–418 of the
protein (Rosas-Acosta and Wilson, 2008). Substitution for alanine
of two hydrophobic residues in this NES (I413A/L416A) increased
nuclear accumulation of BPVE1. Surprisingly however, the I413A/
L416A E1 was severely defective for transient DNA replication
in vivo, but not for E1-catalyzed DNA synthesis in vitro. From these
results, the authors suggested that the nucleo-cytoplasmic shut-
tling of E1 may be required to maintain the protein in a
replication-competent state in vivo (Rosas-Acosta and Wilson,
2008). Another interpretation, however, could be that the I413A/
L416A substitution also affects a function of E1 required in vivo,
but dispensable in vitro, such as its interaction with E2 for
example. Along this line, we note that I413 and L416 lie in
conserved helix α3 of E1, which forms part of the E2 TAD-
binding surface in the co-crystal structure of HPV18 E1 and E2
(Abbate et al., 2004). Thus, it would be important to rule out an
effect of the I413A/L416A substitution on the E1–E2 interaction in
order to conﬁrm the conclusion that nuclear export of E1 is
required for its DNA replication activity in vivo.
The nucleo-cytoplasmic shuttling of BPV1 E1 was also shown
to be regulated by Cdk2-phosphorylation of the protein. How-
ever, and in stark contrast to HPV11 and HPV31 E1, phosphor-
ylation of BPV1 E1 by cyclin A-Cdk2 was found to promote,
rather than inhibit, its shuttling (Hsu et al., 2007). BPV1 E1 was
found to shuttle between the nucleus and cytoplasm using a
classical heterokaryon assay, and to accumulate almost exclu-
sively in the nucleus at the steady-state (Hsu et al., 2007). BPV1
E1 interacts with cyclin A/E-Cdk2 and is a substrate of both
kinase complexes in vitro. The protein contains three putative
Cdk2 phosphorylation sites, T102 and T126 in the N-terminal
region and S283 in the DBD. Through the use of mutant proteins
in which one or all three sites were changed to alanine, it was
found that Cdk2-phosphorylation of BPV1 E1 is dispensable for
its DNA replication activity but, instead, is required to activate
its shuttling during S-phase. The S-phase kinase cyclin A-Cdk2
was found to phosphorylate E1 primarily on S283. Substitution
of this residue by alanine resulted in a mutant E1 that was
unable to shuttle between nuclei in a heterokaryon assay, unlike
what is observed for the wild type protein. Conversely, sub-
stitution of S283 by glutamic acid as a phosphomimetic greatly
stimulated shuttling of the protein and abrogated its ability to
support viral DNA replication in vivo. These results led Hsu et al.
(Hsu et al., 2007) to conclude that Cdk2-phosphorylation of
S283 activates the nucleo-cytoplasmic shuttling of BPV1 E1
during S-phase, perhaps as a mechanism to down-regulate viral
DNA replication and prevent ampliﬁcation of the viral genome
in non-differentiated cells.
Nuclear accumulation of E1 arrests cells in S-phase and triggers
a DNA damage response
Why is the nuclear accumulation of E1 so tightly regulated?
Part of the answer came from the ﬁnding that expression of E1 in
transfected cells blocks cellular proliferation by causing cell-cycle
arrest in S-phase (Fradet-Turcotte et al., 2011; Sakakibara et al.,
2011). This anti-proliferative effect was observed with the E1
proteins from many different PVs (BPV1, HPV8, HPV11, HPV16
and HPV31) and even under conditions of very low E1 expression,
suggesting that it is a general phenomenon and not an artifact of
protein overproduction. Furthermore, this effect depends on the
integrity of the NLS, DBD and ATPase domain of E1, indicating that
cell-cycle arrest is caused by nuclear accumulation of enzymati-
cally active E1. As might be expected when a rogue DNA helicase
gains access to the host genome, the presence of E1 in the nucleusleads to the induction of DNA double-strand breaks and of a
concomitant cellular DNA damage response (DDR), likely as a
result of E1 trying to initiate DNA replication on cellular DNA
(Fradet-Turcotte et al., 2010a, 2011). The E1-induced DDR is
characterized by a robust activation of the ataxia-telangiectasia
mutated (ATM) kinase signaling pathway (Fradet-Turcotte et al.,
2010a, 2011) and, to a lesser extent, of the ATR (ATM and Rad3-
related) pathway (Reinson et al., 2013). Complex formation with
E2 attenuates the ability of E1 to induce a DDR but does not
completely eliminate it, such that DDR markers are still observed
in E1- and E2-induced nuclear foci. Remarkably, transient HPV
DNA replication remains unaffected by the induction of this DDR,
unlike host DNA synthesis which is shut-down by a checkpoint
response (Fradet-Turcotte et al., 2011; King et al., 2010). Overall,
these studies highlighted the importance of regulating the nuclear
accumulation of E1 in order to achieve the optimal balance
between promoting viral DNA replication without interfering with
cellular proliferation. A particularly telling example is the observa-
tion that inactivating the E1 NES in the context of the HPV31
genome results in a mutant episome that induces DNA damage
and is poorly maintained in undifferentiated keratinocytes
(Fradet-Turcotte et al., 2010a).
Although it appears that the levels of E1 must be kept low in
the nucleus of undifferentiated cells, this may not be the case in
differentiated cells undergoing genome ampliﬁcation. It was
previously demonstrated that ampliﬁcation of the HPV31 epi-
some is dependent on the induction of a DDR within differ-
entiated keratinocytes (Moody and Laimins, 2009). While this
study clearly showed that E7 is sufﬁcient for induction of a DDR
within these cells, it remains entirely possible that nuclear
accumulation of E1 also contributes to the magnitude of this
response. More generally, the observations that PVs induce and
require a cellular DDR to amplify their viral genome, and that
mediators of the DDR and components of the DNA repair and
recombination machineries are recruited to viral replication
centers, have been both exciting and perplexing (Gillespie
et al., 2012). One possibility to be investigated is whether these
recruited repair and recombination factors might play a role in
resolving the HPV concatamers produced during rolling-circle
DNA replication into circular monomeric genomes suitable for
viral packaging (Flores and Lambert, 1997). Future studies will
undoubtedly address the molecular function of these host
factors in viral DNA replication and ampliﬁcation and how they
may impinge on the different activities of E1.
Finally, the capacity of E1 to induce DNA damages raises the
possibility that it may participate in the early stages of cancer
induced by high-risk HPVs. Indeed, it is easy to imagine how the
failure to control the nuclear levels of E1 would results in genomic
instability and thus facilitate integration of the viral genome. As
elegantly demonstrated by Kadaja et al., E1- and E2-dependent
onion-skin replication of the integrated genome is an additional
source of genomic instability that could favor cancer progression
(Kadaja et al., 2009). Thus, while we often think of cancer
progression has being solely driven by overexpression of E6 and
E7, undoubtedly the two main drivers of carcinogenesis, we also
need to keep in mind the potential contributions of E1 and E2
during the early stages of disease development.Regulation of E1 by other post-translational modiﬁcations
Phosphorylation
In addition to the phosphorylation events described above
which regulate the nucleo-cytoplasmic shuttling of E1, the protein
can also be a substrate for other cellular kinases. For example,
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on amino acids S48 and S548 (Lentz et al., 2002; Lentz, 2002;
McShan and Wilson, 1997). These sites are also phosphorylated
when BPV1 E1 is expressed in insect cells using a baculovirus
system (Lentz et al., 2006). Both sites conform to the CK2
consensus sequence (S-x-x-[E/D]). Substitution of S48 for a glycine
(S48G) resulted in a mutant E1 protein that is defective for
transient BPV1 DNA replication (McShan and Wilson, 2000).
In contrast, substitution of S48 for aspartate, or for glutamate as
a phosphomimetic, did not alter the replication activity of the
protein (McShan and Wilson, 2000). One- and two-hybrid assays
performed in yeast indicated that the S48G E1 protein retains the
ability to bind to the ori and to interact with E2 and with itself
(oligomerization). Although the precise molecular defect of the
S48G E1 protein could not be identiﬁed, these results nevertheless
support the idea that CK2-phosphorylation of S48 is required for
BPV1 DNA replication. As for serine 584, its substitution by alanine
(S584A) also resulted in a BPV1 E1 deﬁcient for replication (Lentz
et al., 2002). In functional assays in vitro, the S584A E1 retained the
ability to interact with E2 and with Pol α-prim. It also displayed near
wild type helicase activity when tested with a short DNA duplex
substrate. The only defect that was reproducibly detected in vitro
was a reduced capacity to bind to the ori (Lentz et al., 2002). S584
lies in the C-terminal brace of the HD. Given that deletion of this
short region only partially reduces the assembly and stability of E1
hexamers, resulting in a decreased ability to hydrolyze ATP and to
unwind long duplex DNA substrates, it would be interesting to
determine if the S584A substitution also affects the ATPase and
processive unwinding activities of E1. More generally, these ﬁndings
raise the possibility that CK2 regulates the activity of the brace, a
possibility supported by the fact most E1 proteins contain one or
more putative CK2 sites in or near this region of the protein.
Lastly, an attempt was made to identify all of the phosphoryla-
tion sites in E1 by mass spectrometry. In this analysis, recombinant
BPV1 E1 expressed and puriﬁed from insect cells was used to
identify sites that are phosphorylated in vivo, albeit in a hetero-
logous system. Two previously reported sites were conﬁrmed (S48
and S584) and several new ones identiﬁed (S94, S95, S100, T126,
S305) (Lentz et al., 2006). Although the function of the newly
identiﬁed phosphorylation sites remains to be determined, three
(S94, S95 and S100) lie between the two basic regions of the NLS
suggesting that they may regulate the nuclear accumulation of
BPV1 E1. These three sites are predicted to be substrates of CK2.
Ubiquitination
E1 is present at exceedingly low levels in PV infected cells
suggesting that it is synthesized only in low amounts and/or
subject to rapid degradation. Studies performed in Xenopus egg
extracts and in transfected cells have indicated that BPV1 E1 is an
unstable protein that is degraded by the ubiquitin-proteasome
pathway (Malcles et al., 2002). Interestingly, it has been found that
BPV1 E1 is stabilized when complexed with cyclin E/Cdk2,
immediately prior to viral DNA replication, but becomes destabi-
lized following DNA synthesis (Cueille et al., 1998; Malcles et al.,
2002). Proteasomal degradation of E1 requires its poly-
ubiquitination by the anaphase-promoting complex/cyclosome
(APC/C), a multisubunit E3 ubiquitin ligase that regulates mitosis
by triggering the degradation of regulatory proteins such as cyclins
(Mechali et al., 2004). Abrogation of APC/C activity by the natural
inhibitory protein Emi1 led to stabilization of E1 and increased
viral DNA replication. Like many APC/C substrates, BPV1 E1
contains a KEN motif (K-E-N, aa 28–30) and a functional destruc-
tion box (DB, consensus motif: R-x-x-L, aa 346–349) (Mechali
et al., 2004). Mutation of the destruction box (RAFL to AAFA), and
to a lesser extent of the KEN motif (KEN to AAN), stabilized theprotein in transfected cells, providing further evidence that BPV1
E1 is a target of APC/C (Mechali et al., 2004). It was proposed that
the APC/C-mediated degradation of BPV1 E1 helps to maintain the
viral genome at a constant low copy number during latent
infection (Malcles et al., 2002; Mechali et al., 2004). Because the
presence and/or location of the KEN motif and destruction box are
not highly conserved in the E1 proteins of HPV types, it remains to
be determined if the turnover of these proteins is also regulated by
the APC/C ubiquitin ligase.Sumoylation
A two-hybrid screen with HPV16 E1 as the bait provided the
ﬁrst evidence that E1 can interact with the SUMO-conjugating
enzyme Ubc9 (Yasugi and Howley, 1996; Yasugi et al., 1997b).
Subsequent studies indicated that the E1 proteins from BPV1,
HPV1, HPV11 and HPV18 also interact with Ubc9 (Fradet-Turcotte
et al., 2009; Rangasamy and Wilson, 2000). Mapping studies
performed with BPV1 and HPV11 E1 indicated that the oligomer-
ization domain of the protein is required for Ubc9-binding in vitro
but that the complete HD is needed for interaction in yeast. The
DBD, although not sufﬁcient, was also found to contribute to the
strength of the E1-Ubc9 two-hybrid signal in yeast. Accordingly,
several amino acid substitutions in the DBD and HD of E1 were
identiﬁed that could reduce interaction with Ubc9 in yeast (L420P/
K421A for BPV1, K228A, Y380A, N389A, F393A, K484A, K484R for
HPV11, S330R, Y412F, W439R, G482D, G496R for HPV16) (Fradet-
Turcotte et al., 2009; Rangasamy and Wilson, 2000; Yasugi et al.,
1997b). As all of these substitutions in the HD have been shown or
are predicted to affect the enzymatic activity of E1 these results
suggest that a functional helicase is required for interaction with
Ubc9 in the yeast two-hybrid system and, more generally, that
Ubc9 may prefer to interact with oligomeric E1 in vivo (Fradet-
Turcotte et al., 2009).
The E1 proteins from BPV1, HPV1, HPV11 and HPV18 can be
sumoylated in vitro and in vivo, albeit not as efﬁciently as PML, a
well-characterized substrate of the SUMO pathway (Fradet-
Turcotte et al., 2009; Rangasamy and Wilson, 2000; Rangasamy
et al., 2000). Sumoylation of BPV1 and HPV11 E1 can be enhanced
2- to 3-fold in vitro by speciﬁc members of the PIAS family of E3
ligases, and in particular by Miz1, which imparts on BPV1 E1 a
preference for SUMO1- over SUMO2-conjugation (Rosas-Acosta
et al., 2005). The site of SUMO attachment in BPV1 E1 was
identiﬁed by mutagenesis as lysine 514, which is located close to
motif C (sensor 1) in the C-terminal HD (Rangasamy et al., 2000).
Substitution of this residue by alanine or arginine was found to
abrogate the ability of the protein to support transient DNA
replication in vivo (Rangasamy et al., 2000). Initial characterization
of the K514A and K514R mutant proteins indicated that they
accumulated in the cytoplasm rather than in the nucleus of
transfected cells (Rangasamy et al., 2000), but this observation
was later corrected. Indeed, it was subsequently reported that the
K514R mutant protein (the K514A E1 was not tested) accumulates
almost exclusively in the nucleus although it may be slightly more
enriched at the nuclear periphery than the wild type protein,
which shows a more diffuse pattern throughout the nucleus
(Rosas-Acosta and Wilson, 2008). Thus, unlike what was con-
cluded previously, sumoylation of BPV1 E1 is not required for
nuclear accumulation of the protein. A similar conclusion was
reached for HPV11 and HPV16 E1 using mutant proteins defective
for Ubc9-interaction coupled with inhibition of the SUMO path-
way either by the Gam1 protein of the CELO adenovirus, the
dominant-negative Ubc9 C93S or using shRNAs to deplete Ubc9
(Fradet-Turcotte et al., 2009). Thus, the biological consequences of
E1 sumoylation remain largely unknown.
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The productive phase of the viral life cycle takes place in the
uppermost layers of the epithelium. As part of this differentiation-
dependent process, the viral episome is ampliﬁed to more than
1000 copies per cell. Surprisingly, it was found that HPV activates
capases-3, -7, and -9 upon differentiation but without any sig-
niﬁcant induction of apoptosis, suggesting that caspases may play
a role in some aspect of the viral life cycle (Moody et al., 2007).
Through the use of caspase inhibitors, it was discovered that these
enzymes are required for the differentiation-dependent ampliﬁca-
tion of the viral genome. Examination of the sequence of the E1
helicase revealed that one or more putative caspase cleavage sites
(consensus D-x-x-D) are present in the N-terminal region of the
protein. For example, HPV31 E1 contains two overlapping sites,
D-x-x-D-x-x-D between amino acids 46–52. This motif was found
to be efﬁciently cleaved by caspase-3 and -7 in vitro, as well as in
transfected cells treated with a chemical inducer of apoptosis
to activate these caspases (Moody et al., 2007). As anticipated,
substitution of the central aspartate residue for alanine (D49A)
completely eliminated caspase cleavage. The D49A substitution
had no effect on the ability of E1 to support transient DNA
replication in transfected cells indicating that caspase cleavage of
E1 is not required per se for its DNA replication activity. However,
in the context of the complete HPV31 genome, the D49A substitu-
tion prevented ampliﬁcation of the viral episome in differentiated
keratinocytes (Moody et al., 2007). These results suggested that
HPV activates caspases upon differentiation, in part to promote the
cleavage of E1 and ampliﬁcation of the viral episome during the
productive phase of the viral life cycle. The molecular mechanism
by which caspase-cleavage of E1 contributes to the process of
genome ampliﬁcation is currently unknown. More generally, the
ﬁnding that the E1 D49A substitution speciﬁcally impairs ampli-
ﬁcation of the viral episome, while having little to no effect on its
maintenance in undifferentiated cells, provided direct evidence
that E1 is required for this ampliﬁcation process.Concluding remarks
Besides being the only enzyme, E1 is also the largest and
arguably most complex protein encoded by papillomaviruses.
As the replicative helicase, E1 plays a central role in the viral
life cycle. To do so, E1 engages in multiple protein–protein
and protein–nucleic acid interactions to create a novel and critical
interface between the viral origin of replication and the cellular
DNA replication machinery. In systems biology terminology, E1
could be described as a hub protein that rewires the DNA
replication network of the host to maintain and amplify the viral
episome. The last two decades have provided a detailed under-
standing of how E1 and E2 interact with each other to facilitate the
assembly of a replication-competent E1 DH at the origin. Crystal
structures of the E1 DBD, either free or bound to DNA, and of the
E1 HD in complex with the E2 TAD or in its hexameric, helicase-
active form have provided an unprecedented view of how E1
functions as a sequence-speciﬁc DNA-binding protein for ori-
recognition and transits into a non-speciﬁc DNA helicase. Given
that most studies on the assembly of E1 and E2 at the origin were
performed with a fragment of the BPV1 ori containing a single
E2BS, and that most PV origins (including that of BPV1) contain
2 or more E2BS, it is becoming of great interest to investigate if
these extra E2BS can inﬂuence the nature of the E1 and E2
complexes formed at the ori and, more generally, to pinpoint their
exact role in viral DNA replication. As anticipated from its essential
functions, E1 contains some of the most conserved domains of all
PV proteins, most of them located in the HD and being involved inDNA unwinding or in formation of this functional interface with
host DNA replication factors. Region D, however, stands out as one
of the highly conserved regions whose function is still poorly
deﬁned. While it forms part of the interaction interface with E2, its
conservation in SV40 and polyomavirus LT-Ags suggests that it
must also be important for another function of these helicases,
perhaps in hexamerization or interaction with host factors as
suggested by its location within the 3D-structure of these proteins.
Viral DNA replication is also critically dependent on the activity of
the DBD. In recent years, we have come to realize that the function
of this domain is not limited to binding DNA but that it also
participates in key protein–protein interactions required for
assembly of the E1 DT and DH at the ori, or for the recruitment
of speciﬁc host factors to the replication fork. The DBD is the
second most conserved domain of E1. The reason why it exhibits
slightly less conservation than the HD is likely because interaction
with E2 also plays an important role in ori-recognition. Since
formation of the E1–E2–ori complex relies entirely on virally
encoded protein–protein and protein–DNA interfaces, it is less
evolutionary constrained, as highlighted by the fact that the E1
and E2 proteins of different PV types cannot always be inter-
changed in functional assays (Chiang et al., 1992; Gopalakrishnan
et al., 1999; Zou et al., 1998). It will be important to take into
account this heightened genetic variability when considering the
development of antiviral agents that target the E1–E2 interaction, as
it will likely limit the activity of these drugs to a subset of PV types,
as already observed (White et al., 2003). Together, the E1 DBD and
HD are sufﬁcient to support PV DNA replication in vitro and, as such,
constitute the core of the molecular motor that drives PV DNA
replication. In vivo, this process is tightly controlled, in part through
the N-terminal part of E1. This in vivo regulatory region is the least
conserved segment of E1; this greater evolutionarily divergence
likely reﬂecting the adaptation of different PVs to their particular
host. The E1 regulatory region is mostly unstructured and, like many
other disordered protein domains, is rich in short regulatory motifs
and sites of post-translational modiﬁcations arranged in a combina-
torial fashion. An important function of this domain is to regulate
the nuclear accumulation of E1, either by modulating its nuclear
import, export, or both, most often in a phosphorylation-dependent
manner. Although the details of this regulatory mechanism vary
across PV types, it appears that its overall purpose is to synchronize
replication of the viral genome with that of the host and to
determine the magnitude of the replication/ampliﬁcation process
during the different phases of the viral life cycle, by controlling the
amount of E1 in the nucleus. It is likely that other cellular factors
that regulate and/or participate in PV DNA replication will be
discovered in the future, in particular as it pertains to the roles of
the cellular DNA damage and repair pathways in this process. Many
host proteins and enzymes have already been found to interact with
E1. While few of these interactions have been shown to be essential
for PV DNA replication to date, it is likely that at least a subset of
them will be. As further research identiﬁes and characterizes these
critical E1-host factor interactions, we anticipate that the E1 protein
domains required for binding these cellular proteins will be highly
conserved, perhaps even more so than those involved in E2-binding
given that cellular targets exhibit far less genetic variation than E2.
This may pave the way to the identiﬁcation of small-molecule drugs
that modulate these E1-host protein interactions and re-invigorate
research into targeting E1 for the development of anti-PV drugs,
which, unfortunately, has been met with little success so far due to
the intrinsic plasticity of the enzyme catalytic site. In addition to
remaining a valid drug target, E1 also continues to be a model
enzyme for the study of helicase activity. We can be sure that
additional research into the structure and function of E1 will lead to
further insights into the mechanisms of DNA unwinding and
eukaryotic DNA replication in general. The great number of
M. Bergvall et al. / Virology 445 (2013) 35–56 53functional E1 enzyme sequences available in the PaVE database will
undoubtedly be of great assistance to those interested in these basic
and therapeutic research areas.
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